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1. Introduction 
 
The amount of fish killed for human feeding and the consumer demand for fish 
are increasing each year rapidly, as well as the world’s human population. The 
populations of wild fish are decreasing because of overfishing and, 
consequently, the number of farmed fish has increased greatly during the last 
decades. From previously answering for 9% of the total of fish killed for human 
consumption in the middle of the 1980s, aquaculture system produced 46% of 
the eaten fish in 2008 (Food and Agriculture Organization of the United Nations, 
2010), although this percentage is lower in the developing countries. The rising 
consumer demand for high quality fish meat, as well as the increasing public 
concern for fish welfare and environmental sustainability, had led to a boom of 
demand for improvements of fish farm practices (Lambooij et al, 2004). Besides, 
the increasing public alarm concerning fish wellness in aquaculture (Huntingford 
et al, 2006), has resulted in a substantial amount of research during the last 
decade. Aquaculture production has risen by almost 12-fold in the last three 
decades (FAO, 2012). Aquafeed is based on fish meal and fish oil because of 
their high nutritional quality; however, the sustainability of this practice is not 
occurring at present, especially over the long term (Watanabe, 2002). Moreover, 
in order to reduce aquafeed costs and decrease overexploited marine fisheries 
pressure, research efforts to find suitable alternatives are currently underway. 
The use of raw plant materials, as protein and lipid sources, has been 
considered and approved as a sustainable alternative to fish products (Bouraoui 
et al., 2011; Nasopoulou and Zabetakis, 2012); nevertheless, proteins continue 
to be the most expensive nutrients and, in an attempt to spare protein energy in 
several fish species, lipid content is rising (Company et al., 1999; Watanabe, 
2002; Li et al, 2012). The current trend to use high-lipid diets has been shown to 
induce undesirable increase in fat depots or even physiological alterations such 
as induction of oxidative stress (Kiaer et al., 2008). Some aquaculture practices, 
such as the employment of hyperlipidic diets or new raw dietary materials, in 
synergism with the moderate swimming activity of reared fish, might have 
negative effects, contributing to reduce fish growth and animal welfare and 
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increasing visceral adiposity (Benedito-Palos et al., 2008; Montero et al., 2003). 
Fat increment can induce precocious sexual maturation, alterations in lipid 
metabolism, as well as a change in the fatty acid profile of the flesh (Cruz-
Garcia et al., 2011; Einen and Skrede, 1998). Fat mass increase might be due 
either to hypertrophy (build up in size of existing adipocytes) or to hyperplasia 
(rise in cell number by proliferation of precursor cells). Fish oil is the most 
common source of lipid used in fish feeding, in particular for carnivorous 
species. Many favourable characteristics contribute to this massive use of fish 
oil in aquaculture: in fact it is the best source of digestible energy, it is readily 
palatable by the farmed fish, it contains essential fatty acids, it does not affect 
flesh composition and taste of the flesh and can spare protein utilization to 
varying degrees (Sargent et al., 2002; Olivia-Teles, 2012). The falling in global 
fish oil availability, from 1.5 million tons in 1994 to 1.07 million tons in 2009 
(FAO, 2012), due to the depletion of world fisheries resources, environmental 
concerns related to fish oil production, expansion in global aquaculture 
production and the development of fish oil-based tablets for human 
consumption, during the last two decades, concur with the rise in fish oil cost 
(Klinger et al., 2012; FAO, 2012; NRC, 2011). At present, a rising proportion of 
fish for human nutrition comes from aquaculture, where formulation of feeds 
with fish meal and fish oil ensures n-3 LC-PUFA (Long Chain Polyunsaturated 
Fatty Acid) rich meat production. Together with the expansion of aquaculture, 
the demand for this marine products also increases, but global supply has 
stagnated and the reduction of fishery that provides it is considered 
unsustainable and over-exploitative of natural resources (Naylor et al., 2000). 
When addressing the imminent deficiency, replacement of fish oil by vegetable 
oils challenges the maintenance of the recognized health benefits due to n-3 
LC-PUFA content. Several studies have shown that complete or partial 
substitution of fish oil with single vegetable oil such as rapeseed oil, linseed oil, 
palm oil or with a vegetable oil blend has reduced effect on growth but marked 
consequences on lipid metabolism, tissue lipid composition and correlated 
factors such as digestibility, fatty acid catabolism, lipid transport and uptake, 
lipogenesis, fatty acid desaturation and elongation and eicosanoid synthesis 
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(Turchini et al., 2009; Leaver et al., 2008; Panserat et al., 2008). Overall, dietary 
fatty acid composition is reflected in the flesh and lipid stores of the fish. 
However, the magnitude of the change is dependent on the species and fatness 
deposition of tissue (Turchini et al., 2009). Aquaculture’s dependence on marine 
oils is considered as one of the major constraints in determining the sector’s role 
in fisheries conservation (Naylor et al., 2009). In this way, in addition with 
economical problems, it is not strange that fish oil replacement is a major issue 
of focus in farmed fish nutrition research and development (Turchini et al., 
2009). A different multitude of chemical, biochemical and physiological effects of 
the introduction of alternative dietary lipid sources for farmed fish have been 
intensively studied over the past two decades (Turchini et al., 2010). Apart from 
this, there is very little information about the potential effects of different dietary 
lipid sources on lipid peroxidation and the consequential formation of DNA-
reactive compounds, which can significantly affect overall fish health. Many 
studies in mammals have underlined and revealed the main role of oxidative 
stress and lipid peroxidation in carcinogenesis and that DNA adducts generated 
by lipid peroxides are associated with an inflammatory process in their 
etiopathogenesis (Blair, 2008; Cooke et al., 2003; Hagenlocher et al., 2001; 
Medeiros, 2009; Nair et al., 1997; Nair et al., 2007). To limit lipid peroxidation, 
all organisms which practice aerobiosis have got two types of antioxidant 
defense systems: free radical scavengers, usually of low molecular weight, and 
antioxidant enzymes (Halliwell and Gutteridge, 2007). These antioxidant 
enzymes are active during the overall development of O. mykiss and are 
modulated by feeding moderate levels of oxidized lipid (Fontagnè et al., 2008). 
Early stages of fish’s development seem to be particularly sensitive to oxidative 
stress caused by the overpowering effects of prooxidants on antioxidant 
defenses of cells that can induce alteration in development (Boglione et al., 
2013; Fontagnè et al., 2006; Hata and Kaneda, 1980; Lewis –McCrea and Lall, 
2007, 2010). Early life stages of fish also need a dietary phospholipid supply for 
good development (Boglione et al., 2013; Cahu et al., 2009; Tocher et al., 
2008). It has been shown that a diet rich in phospholipids plays an active role in 
absorption of neutral lipids in fish, even if phospholipids are also known to exert 
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an antioxidant effect on different oils and fats, due not only to the side-chain 
amino group but also to the conjunct effect of the hydroxyl group in the side-
chain (Tocher et al., 2008). Some studies have demonstrated the efficiency of 
single and combined treatments with natural antioxidants in the inhibition of lipid 
oxidation of fish oil and muscle (Fagbenro and Jaucey, 1994; Pazos, Alonso, 
Fernández-Bolaños, Torres and Medina, 2006; Pérez-Mateos, Lanier and Boyd, 
2005; Shahidi and Naczk, 1995; Tang, Sheehan, Buckley, Morrissey and Kerry, 
2001). In addition to the ongoing debate about the use of synthetic food 
additives, such results have lead to the introduction of plant extracts as 
antioxidants in food that contains fish oil, and this fact became a common 
practice in the last years. Antioxidants are naturally found in combination with 
other compounds usually in the form of esters. Similarly to other phenolic 
compounds, they can directly trap free radicals or scavenge them through a 
series of coupled reactions with antioxidant enzymes, in this way delaying the 
starting of lipid oxidation via the decomposition of hydroperoxides (Lewis, 1993). 
In the past, dietary fish content in fish nutrition was limited by the production 
technology and pelletized feeds of 1970s-1980s contained dietary lipids ranging 
between 8% and 15% (Johnsen and Wandsvik, 1991). A major trend for 
commercial diets for salmonids has been the development of extruded high-
nutrient or high-energy diet which have shifted the upper limit of fat content in 
dry feed to 20-30% (Cho and Cowey, 1991; Green et al., 2002; Karalazos et al., 
2007), and even 47% (Hemre and Sandnes, 1999). This kind of diet has got 
many advantages, which include better growth, feed utilization, nitrogen 
(protein) retention and reduced nutrient discharges in the environment (Alstead, 
1991; Cho, 1992; Hillestad and Johnsen, 1994) and protein sparing effect 
(Sargent et al., 2002). In every case, there is a strong relationship between high 
dietary lipid levels and undesirable metabolic consequences beyond limited 
dietary protein utilization as source of energy. Such consequences include 
growth delay due to reduced feed consumption (Daniels and Robinson, 1986; 
Ellis and Reigh, 1991; Page and Andrews, 1973; Watanabe, 1982), increase in 
body lipid deposition and its effect on carcass quality (Bromley, 1980; Hillestad 
and Johnsen, 1994). 
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1.1 Anatomy, biology and habitat of the Rainbow trout (Oncorhynchus 
mykiss) 
 
Considerable attention has been focused on maximixing the production of 
farmed salmonids at minimal cost even if, in recent years, there has been a 
rising care on ways in which the food quality attributes of reared fish can be 
manipulated (Haard, 1992; Shearer, 1994). The rainbow trout, Oncorhynchus 
mykiss (Walbaum, 1792), is a salmonid species that is widely spreaded 
because of its introduction into many countries for farming and sport fishing 
purposes. Such is the economic importance of the rainbow trout that entire 
symposia have been devoted to discussions of the biology and cultivation of the 
species (e.g. Gall, 1992).  
The rainbow trout (Class: Actinopterygii; Order: Salmoniformes; Family: 
Salmonidae; Genus: Oncorhynchus; Species: O. mykiss) (Fig. 1) is a member 
of the Pacific trout and salmon subgroup of the salmon family which also 
includes the redband trout, the cutthrout trout and the golden trout. The name of 
this species means ‘’hooked snout’’ refering to the distinctly hooked upper or 
lower jaw of mature males.   
 
 
 
Fig. 1. Image of the O. mykiss (Source: C. Griffiths). 
 
Rainbow trout has a fusiform body shape that is usually olive-green dorsaly with 
brassy to purple iridescence; back and sides are marked with dark olive to black 
spots, even if this fish is highly variable in colour. The dorsal, adipose and 
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caudal fins are light olive to amber marked with dark coloured spots. Lower fins 
are usually pale shades of amber, orange, red, purple or gray while the anal and 
pelvic fins are often white tipped. There are radiating rows of black spots on the 
caudal fin and a pink to red stripe on the side. The upper jaw reaches barely 
behind the eye in young and female individuals but well behind the eye in large 
males. The largest rainbow trout ever captured was 1.22 m and 16.3 Kg (GISD, 
2012); the average river O. mykiss in South Africa is approximately 0.5 m of 
lenght and 1.5 Kg of weight (Picker and Griffiths, 2011). O. mykiss is a fish living 
in cold water native to North America from Alaska to Mexico (Fig. 2): it is mainly 
a freshwater species which need of high quality, unpolluted and well-
oxygenated water to survive.  
 
 
 
Fig. 2. Native (green) and introduced (red) distribution of O. mykiss in the world 
(Source: GISD, 2012). 
 
Some rainbow trout populations are migratory and spend the majority of their life 
in seawater, returning to freshwater just to breed; for this cause they have an 
anadromous life cicle. About the life span of wild rainbow trout, maturation starts 
before they are one year old with average survival of three to four years; the 
maximum known longevity is eleven years. Because of its anadromous nature, 
rainbow trout can survive in a range of salinity from 0 to 35‰ (Molony, 2001) 
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and dissolved oxygen levels seem to be the major limiting factor for this species, 
with the minimum O2 concentration estimated in 2.5 mg/L (Rowe and Chisnall, 
1995). Wild individuals of O. mykiss typically spawn during the late winter and 
spring with a peak in March and April when water temperatures are between 10 
and 15°C. Spawning actitvity occurs once a year and it is usually induced by 
increasing day lenght, water flow and water temperature. Females of O. mykiss 
are able to produce 2000 eggs/Kg of body weight. Rainbow trout are 
opportunistic feeders that prey on invertebrates, small fish, fish eggs and 
aquatic insects, although, in the wild, O. mykiss eat freshwater shrimps, 
responsible for the fish’s pink flesh. Rainbow trout was first farmed in 1879 in 
California. After, during the 19th and 20th centuries, this species spread across 
the world and today aquaculture of O. mykiss is more popular in its introduced 
range than in its native one (Vandeputte et al., 2008). In the 1950s, farming of 
rainbow trout expanded with the diffusion of feed in a pelleted form. At present, 
the majority of the farming is in the form of extensive monoculture. The main 
standards on which this kind of aquaculture is based is the availability of good 
quality and well aerated water, so that trouts can be reared in the following 
systems: 1) in concrete raceways or ponds with a continuous supply of flowing 
river water, 2) in tanks connected to recirculating systems or 3) in cages that are 
usually anchored in dams (FAO, 2012). O. mykiss has been introduced to 
almost all continents, except Antarctica, for the purpose of angling and 
aquaculture (FAO, 2012) and this introduction has taken place in at least 87 
countries (GISD, 2012) (Fig. 2). The incredible spreading of trout aquaculture is 
helped by easy production and technological advances in culture techniques, 
allowing trout farming to be possible in almost every environment with a suitable 
supply of cold clean water. Because of rainbow trout spreading and popularity, it 
has been classified and listed as one of the World’s Worst 100 Invasive Alien 
Species (GISD, 2012) and this list has been compiled by the Global Invasive 
Species Database and La Fondation TOTAL d’Enterprise in collaboration with 
the International Union for Conservation of Nature (IUCN) and the Invasive 
Species Specialist Group (ISSG).   
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1.2 Metabolism and functions of adipose 
tissue in Teleost fish 
 
The term ‘’lipid’’ is used referring to a wide and miscellaneous kind of 
substances which are grouped together because of their high solubility in non-
polar solvents or their similarities to them. Lipids usually contain fatty acids 
esterified to alcohol groups in the case of glycerides and to amino groups in the 
case of sphingolipids. Animal lipids, including fish lipids, can be divided into two 
groups, polar lipids, composed mainly of phospholipids, and neutral lipids 
composed principally of triacylglycerol (triglycerides). At ambient temperature, 
triacylglycerols can be either solid, in which case they can be named fats, or 
liquid, in which case they can be termed oils. Fish triacylglycerols are invariably 
oils. The most part of lipid compounds in eukaryotes organisms derives from 
acetyl-CoA and can be part of one of the three main classes of substances: 1) 
straight chain fatty acids, 2) branched, cyclic and other specialized fatty acids, 
3) polyprenoid compounds, which include carotenoids and sterols with all their 
derivates. Lipids have a crucial role in the structural composition of cell 
membranes and are indispensable for energy supply and storage. Lipids and 
fatty acids, together with proteins, are the most important macronutrients for fish 
(Sargent et al., 2002). Based on previous studies, fish have not evolved efficient 
systems to employ carbohydrates in their metabolism unlike terrestrial 
vertebrates, in which carbohydrates represent the major components of their 
diet. In this way, carbohydrates are quantitatively less important as nutrients for 
the majority of the fish than the other vertebrate organisms. This fact suggests 
that fish may obtain structural carbohydrates and storage carbohydrates 
(glycogen) mainly catabolising amino acids (Cowey and Walton, 1989). Fish 
exhibit a lot of unique aspects of lipid metabolism. Unlike homeotherms, which 
store lipid in a single depot site (adipose tissue) mainly as triacylglycerol, fish 
store a big quantity of lipids among many depots (mesenteric fat, liver and red 
muscle) as triacylglycerol and other lipid classes. Besides, the constituent fatty 
acid of fish tend to be more complex (longer chain length and higher degree of 
unsaturation) comparing with those of homeotherms (Sheridan, 1988). Lipid 
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accumulation is influenced by new lipid synthesis and even by the deposition 
from different plasma lipoproteins. For example, lipoprotein lipase (LPL) 
hydrolyzes triacylglycerols and phospholipids in chylomicrons and very low 
density lipoproteins, making possible the uptake of the lipid products into the 
neighbouring tissues (Lindberg and Olivecrona, 2002). In condition of 
metabolism need and demand, stored lipids are mobilized from depot sites by 
the action of hormone-sensitive lipase (HSL) (Sheridan, 1988, 1994; Gonzalez-
Yanes and Sanchez-Margalet, 2006). White adipose tissue is an organ highly 
specialized in storing and releasing lipids, in the form of triglycerides, in 
response to a variety of signals controlling energy balance. In addition, it has the 
function of an endocrine organ (Harwood, 2012) secreting a multitude of 
adipokines that regulate different physiological processes such as appetite, 
glucose metabolism, immunity, inflammatory responses, angiogenesis, blood 
pressure and fertility (Ali et al., 2013). The study of fat deposition has become a 
key area of interest in fish farming with the aim of obtaining high quality 
products, rich in good nutritional elements, and maintaining fish health. The 
management of high lipid feed can lead to an undesired increase in fat 
deposition that alters sensory and organoleptic characteristics (Kjaer et al., 
2008; Turchini et al., 2009). Moreover, some studies have been conducted 
about the lipid metabolic disorders in association with the content and type of 
lipids in the diet (Turchini et al., 2009; Benedito-Palos et al., 2008) and the 
dietary effects on macrophage function and stress susceptibility (Sitjà-Bobadilla 
et al., 2005; Gjøen et al., 2004).  
 
Digestion 
 
Lipolytic activity in fish is usually very intense in the proximal part of the 
intenstine and the pyloric caeca if present, but it might be extended into the 
lower part of the intestine with the activity decreasing progressively. The 
pancreas or hepatopancreas is generally considered to be the major source of 
digestive lipase enzymes in both fish and mammals (Kapoor et al., 1975; Fange 
and Grove, 1979). Moreover, digestive lipases may also be secreted by the 
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intestinal mucosa, as many studies have found high lipase activity in mucous 
layers or intestinal segments of several fish species, although these lipase 
activities might come from the pancreas, resulting from the absorption of 
pancreatic enzymes into the intestinal mucosa (Fänge and Grove, 1797; 
Smith,1989a). There is other evidence, such as that of substrate specificities, 
that supports the idea that intestinal cells can actively secrete lipolytic enzymes 
(Borlongan, 1990; Uematsu et al., 1992; Koven et al., 1994a). Lipolytic activity 
crosschecked in stomach is not probable of pancreatic origin and this fact 
suggests the hypothesis that this tissue is also a source of lipases, not 
excluding a bacterial origin for some lipolytic activities in the digestive portion of 
fish (Olsen and Ringo, 1997). 
Triacylglycerol is the most extensive lipid class present in the diet of marine fish 
and it is usually the main component in the diet of freshwater fish too. In 
mammalian gut, triacylglycerol hydrolysis is caused by two main lipases, the 
pancreatic lipase-colipase system (EC 3.1.1.3) and the less specific bile salt-
activated lipase (EC 3.1.1.1). Many evidence indicate the presence of a bile 
salt-activated lipase in teleost fish; stimulation of lipolytic activity has been found 
in intestinal extracts by bile salts both in marine and freshwater fish (Olsen and 
Ringo, 1997). It was seen that lipase activity in O. mykiss pyloric caecal extracts 
widely disappeared upon removal of bile salts by dialysis and it was restored by 
adding exogenous bile salts and also, porcine colipase was not capable of 
preventing the inhibition of lipolytic activities by cholate (Tocher and Sargent, 
1984a).  
Moreover, phospholipids, especially phosphoglycerides, constitute an important 
part of the dietary lipid in fish. It is presumed that both in fish and mammals, 
dietary phosphoglycerides are digested by pancreatic or intestinal 
phospholipases with the consequent formation of 1-acyl lyso-
glycerophosholipids and free fatty acids which are absorbed by the intestinal 
mucosal cells (Henderson and Tocher, 1987; Sargent et al., 1989). It is not clear 
yet if fish possess a specific wax ester hydrolase, since no specific enzymes 
have been purified or characterised. 
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Absorption 
 
The main products of lipid digestion in fish are free fatty acids produced by 
lipolytic activity on all major lipid classes. Moreover, in fish the partial action of 
acylglycerols, especially of 2-monoacylglycerols, plays an important role, but 
probably also the activity of diacylglycerol and glycerol from the digestion of 
triacylglycerols (1-acyl-glycerophospholipids from the digestion of 
phosphoglicerides) are important and cholesterol and long chain alcohols come 
from the hydrolysis of cholesteryl and wax esters, respectively. Identically to 
mammals, lipid absorption in fish happens mostly in the proximal part of the 
intestine that coincides with the highest lipolytic activity. Anyway, lipid 
absorption happens along the entire lengh of the intestine, even if in diminishing 
amount. In the intestinal mucosal cells, the main destiny of the absorbed fatty 
acids is the re-esterification with glycerol, in part acyl glycerol and 
lysophospholipids to reform triacylglycerols and phosphoglycerides (Sargent et 
al., 1989). Sterol and wax esters might be reformed, even though free 
cholesterol is easily transported from the mucosal cells and the wide majority of 
fatty alcohols are oxidised to the relative fatty acid in the epithelial cells 
(Bauermeister and Sargent, 1979). The most part of the phosphoglycerides are 
absorbed and digested through 1-acyl-phosphoglyceride intermediate by re-
esterification, before being exported from the intestinal cells. 
 
Transport 
 
In the extracellular transport mechanism, lipids are exported from the intestine in 
the form of lipoproteins. The reactions of re-esterification take place above all in 
the endoplasmic reticulum, leading to the production of chylomicrons, like very 
low density proteins and particles in the lumen, as it was observed in particular 
for freshwater species. Chylomicrons are produced exclusively in the intestine 
but, although some very low density lipoprotein (VLDL) can also be synthesized 
in the gut, the majority of VLDL which are in the plasma are synthesized in the 
liver. The main enzymes of lipoprotein metabolism and remodelling, 
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encountering LPL and hepatic lipase have been found in both marine and 
freshwater fish. The lipid amount and their degree of unsaturation bears upon 
lipoprotein production, with high dietary lipid and PUFA, bringing to the 
production of larger chylomicrons, while high dietary fatty acids result in the 
production of smaller VLDL particles. In mammals, the transport of intestinal 
lipoproteins happens from the intestine especially trough the lymphatic system. 
In a similar way, in fish the majority of the intestinal lipoproteins are transported 
via the lymphatic system before appearing in the circulatory system and they 
are delivered to the liver (Sheridan et al., 1985). Anyway, a part of intestinal 
lipoproteins might also be transported directly through the portal system. Teleost 
fish have a major plasma protein with almost the same size, solubility and 
electrophoretic mobility of mammalian serum albumin (De Smet, 1978) and this 
protein plays an important role in transporting free fatty acids in the blood from 
adipose tissue depots to peripheral tissues under appropriate physiological 
conditions, as it happens in mammals (Sheridan, 1988). The intracellular 
transport of free fatty acids in mammals is helped by specific low molecular 
weight and highly conserved cytoplasmic proteins that bind either long-chain 
fatty acids or other hydrophobic ligands. These fatty acid binding proteins 
(FABPs) are tissue specific and those from liver, intestine, adipose tissue, brain 
and heart have been widely characterised in mammals (Veerkamp and 
Maatman, 1995). Many FABPs have been analysed from fish tissues, such as 
the elasmobranch liver (Bass et al., 1991; Baba et al., 1999; Cordoba et al., 
1999). The FABP purified from the liver of the catfish (Rhamdia sapo) seemed 
to result more similar to the chicken liver FABP than to the FABPs of 
elasmobranchs or mammals (Dipietro et al., 1996). Intracellular FABPs were 
studied also in different species of Antarctic fishes (Londraville and Sidell, 1995) 
and two distinct types were isolated from heart tissue, one similar to the 
mammalian heart-type and the other closed to mammalian adipose tissue-type 
(Vayada et al., 1998). The deduced protein sequence for the trout heart FABP 
resulted 75% identical to that of rat heart FABP (Ando et al., 1998). These 
findings support the general thesis that intracellular transport of fatty acids in 
fish is essentially the same of higher vertebrates. 
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Fig. 3. Trans-membrane fatty acids transport and their intracellular activation, 
together with the main pathways of activated fatty acids that might explain 
intracellular triacylglycerol storage. FA= Fatty Acid; FATP= Fatty Acid Transport 
Protein; FAT= Fatty Acid Translocase; ACS= Acyl-coenzyme A Synthase; 
NEFA= Non-esterified Fatty Acid; FABP= Fatty Acid Binding Protein; ACBP= 
Acyl-coenzyme A Binding Protein; MTP= Microsomal Triglyceride Transfer 
Protein and TAG= Triacylglycerol (Source: Journal of Animal Physiology and 
Animal Nutrition, 2008).  
 
Lipogenesis 
 
The process of lipogenesis concerns to the biosynthetic reactions that bring to 
the formation of new endogenous lipid. The ultimate carbon source for the 
biosynthesis of new lipids is acetyl-CoA, formed in mitochondria from oxidative 
decarboxylation of pyruvate (carbohydrates source) or the oxidative breaking of 
some amino acids (proteins source). The central pathway in lipogenesis is 
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catalysed by the cytosolic fatty acid synthetase (FAS), a multienzyme complex 
that has been described in fish (Sargent et al., 1989). The most important 
products of FAS are the saturated fatty acids 16:0 (palmitic acid) and 18:0 
(stearic acid) which all known organisms, fish included, are able to 
biosynthesise ex novo (Sargent et al., 1989). To biosynthesise saturated fatty 
acids 16:0, eight two-carbon acetyl units are indispensable: one acetyl-CoA unit 
has the function of a primer while the other seven acetyl units are carboxylated 
by acetyl-CoA carboxylase to malonyl-CoA, to be combined through FAS in a 
series of sequential condensation steps requiring nicotinamide adenine 
dinucleotide phosphate (NADPH) (Henderson and Sargent, 1985). Other key 
pathways in lipogenesis have the aim of creating the reducing elements, 
NADPH, encompassing enzymes of the pentose phosphate pathway and 
malate dehydrogenase, with glucose-6-dehydrogenase probably being the main 
NADPH generating enzyme in fish (Dias et al., 1999). Despite adipose tissue 
exerts some lipogenic activity in rainbow trout, liver is quantitatively the main 
site of lipogenesis in this species (Henderson and Sargent, 1985). In addition, 
referring to carbon sources, the rate of fatty acid synthesis from alanine was 
remarkably greater than that from glucose in trout liver, bringing to the 
conclusion that amino acids are the favourable carbon source for lipogenesis in 
this fish. The rate of lipogenesis is regulated by a number of dietary/nutritional 
factors; in particular it was seen that a diet rich in lipids suppresses lipogenesis. 
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Fig. 4. Lipogenesis and lipolysis pathways (Source: lookfordiagnosis.com). 
 
Triacylglycerol mobilisation 
 
Triacylglycerols are accumulated in adipose tissue mainly as a long-term source 
of energy useful when the energy requirement of the animals exceeds that 
available from the diet. An example of this mechanism in fish happens during 
reproduction when the production of a huge number of gametes is very 
intensive in terms of energy. Other examples might be starvation and the long 
distance migrations that happen before the moment of reproduction in many fish 
species: fish energy requirements are very high because of swimming red 
muscles consumption, so that energy is greatly provided by fatty acids. Lipids 
are probably mobilised initially from the main adipose tissue, even though later 
they will be mobilised from the secondary lipid storage organs (muscle and 
liver). A necessary enzyme in triacylglycerol mobilisation is HSL, which is 
regulated by different hormones through reversible phosphorylations by the 
action of kinases and phosphatases under the influence of many activators and 
inhibitors. It has been seen that the process of triacylglycerol mobilisation is 
under hormonal control, at least in the liver, indirectly implying the presence of 
HSL in fish (Sheridan, 1994). Other studies demonstrated that triglycerides 
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mobilisation in trout was regulated through the phosphorylation state of the 
triacylglycerol lipase in both liver and adipose tissue (Sheridan, 1994). In this 
way, during starvation or periods of sober, lipid mobilisation from liver and 
adipose tissue, either in fish or in mammals, is under ß-adrenergic control with 
adrenalin and noradrenalin that stimulate tricylglycerol hydrolysis and the 
increase of free fatty acids in the plasma in salmonids and in other fish orders, 
although the influence of the two catecholamines is not the same among 
different species (Sheridan, 1994; Fabbri et al., 1998). Apart from this, many 
other hormones (glucagon, cortisol, adrenocorticotropic hormone, growth 
hormone, somatostatin, thyroxine and prolactin) act to stimulate lipid 
mobilisation in depot organs, liver in particular, through the activation of HSL, 
bringing to the breakdown and the secretion of free fatty acids; on the contrary 
insulin inhibits the activity of HSL (Sheridan, 1994). 
 
Fatty Acid Catabolism 
 
Fatty acid catabolism is the major source of energy in many species of fish. The 
biosynthesis of fatty acids happens in the cytosol, instead their catabolism 
occurs in mitochondria and in peroxisomes through a completely different set of 
enzymes. The whole process is given the name of ß-oxidation and involves the 
sequential cleavage of two-carbon units, released as acetyl-CoA, through a 
cyclic series of reactions catalysed by several distinct enzyme activities rather 
than a multi-enzyme complex. Activated fatty acids are brought to the inner 
membrane of mitochondria in the form of fatty acylcarnitine esters, formed by 
the action of carnitine acyltransferase, converted back into fatty acid acyl-CoA 
derivates and then undergo a round of dehydrogenation, hydration, second 
hydrogenation and cleavage steps to produce acetyl-CoA and NADH. The 
acetyl-CoA can be metabolised through the tricarboxylic cycle in order to form 
more NADH, which can provide metabolic energy in the form of ATP via the 
process of oxidative phosphorylation. In sober condition or starvation, acetyl-
CoA can be exported from the liver as ketone bodies (acetoacetate and 3-
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hydroxybutyrate), which are employed by peripheral tissues as a source of 
energy through re-oxidation to acetyl-CoA.  
 
1.3 Lipid metabolism in liver 
 
The major role of the liver is to maintain a fairly constant supply of circulating 
nutrients during variations in dietary intake. The maintenance of blood glucose 
levels in starvation periods is absolutely important because the brain has a great 
requirement for glucose. The response to hunger is controlled by a rise in the 
circulating levels of glucagon and glucocorticoids and a fall in the levels of 
insulin. During short period of fasting, liver glycogen is mobilized to release 
glucose. As fasting continues, gluconeogenesis from pyruvate, lactate, glycerol 
and amino acids begins. Gluconeogenesis from dietary proteins will also occur if 
the diet is poor in carbohydrates. Fatty acids can not act as substrates for 
gluconeogenesis, so the major energy store in the body can not be used to 
maintain blood glucose and the animals have to rely on proteins. During the 
period of fasting the energy requirements of the liver are supplied by the 
oxidation of fatty acids from the circulation that will have been mobilized from 
adipose tissue. Fatty acids can also be converted to ketone bodies that are 
released into the circulation and have the function of alternative fuel. In a 
situation of well feeding, the direction of metabolism goes towards the storage of 
glycogen and the synthesis of triacylglycerols, which are synthesized from fatty 
acids, derived from circulating chylomicrons and from fatty acids synthesized in 
the liver too. The liver storage of fatty acids is very little but the majority are 
exported as lipoproteins from the accumulated adipose tissue. Many studies 
have shown that glucose is a poor substrate for liver at any circulating 
concentration under the threshold of about 12 mmol/L. It appears that 
gluconeogenic precursors are better substrates than glucose for both fatty acid 
and glycogen biosynthesis. As soon as the blood glucose increases, the 
metabolism of gluconeogenic substrates switches from the production of 
glucose towards glycogen synthesis, fatty acid synthesis and also oxidation 
through the citric acid cycle for energy production. The liver is also the most 
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important organ for the biosynthesis of purines and steroids and the only one 
that synthesizes urea (Martin, 1987). 
 
Fatty acid oxidation and biosynthesis 
 
After the entry of fatty acids into the cell, they are esterified with coenzyme A; 
the pyrophosphate produced is rapidly hydrolysed to inorganic phosphorus, 
increasing the overall negative free energy of the reaction, making more 
favourable the production of acyl CoA. The mitochondrial membrane is 
impermeable to fatty acyl CoA, so fatty acyl units are put inside the 
mitochondria, where ß-oxidation takes place, through the carnitine shuttle. This 
event involves the synthesis of acyl carnitine from acyl CoA and carnitine in the 
cytoplasm and the regeneration of acyl CoA in the mitochondria by the reverse 
reaction. Acyl carnitine enters the mitochondria on a carrier in exchange for free 
carnitine. The cytoplasmic transferase is inhibited by malonyl CoA, one of the 
intermediates in the biosynthesis of fatty acids, formed in the cytoplasm by 
acetyl CoA carboxylase, which is the first enzyme exclusively involved in fatty 
acid biosynthesis. This enzyme is activated by insulin and inhibited by 
adrenaline. The main carbon sources for fatty acid biosynthesis are fructose and 
lactate, in contrast with fat cells where the main carbon source is glucose. 
The level of circulating free fatty acids is determined mainly by the rate of 
lipolysis in adipose tissue. Lipolysis is activated by glucagon during starvation 
and by adrenaline during stress or exercise and both these processes work 
through cyclic AMP. Insulin inhibits lipolysis and the downfall in the circulation of 
this hormone is the main factor in rising rates of lipolysis during hunger. In this 
way, the rate of fatty acid oxidation is under hormonal control but its effect is 
indirect because it is a consequence of the hormonal effects on the different 
tissues. An increase in fatty acid oxidation in the liver brings to a marked rising 
in the level of acetyl CoA in the mitochondria and this fact is seen as an 
important signal for the activation of gluconeogenesis and ketone bodies 
biosynthesis (Martin, 1987). 
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Fig. 5. Main steps of fatty acid oxidation and synthesis. CPT I, CPT II= Carnitine 
Palmitoyltransferase I and II); mHMG-CoA-synthase= Mitochondrial 
Hydroxymethylglutaryl-coenzyme A synthase; cHMG-CoA synthase= Cytosolic 
HMG-CoA synthase) and TCA= Tricarboxylic Acid Cycle; FA= Fatty Acids 
(Source: Journal of Animal Physiology and Animal Nutrition, 2008).  
 
 
 22 
 
 
= inhibition/ defect; = increased activity/ content 
 
Fig. 6. Fatty acid oxidation path in liver (Source: ajpgi.physiology.org).  
 
Ketone bodies synthesis 
 
In a period of starvation, mitochondrial acetyl CoA levels grow because of 
increased fatty acid oxidation and the main factor involved in the regulation of 
ketone bodies synthesis is the resulting substrate stimulation of ß- 
hydroxymethyl glutaryl CoA synthetase (HMG-CoA synthetase), an enzyme 
inhibited by succinyl CoA. In every case, glucagon or dibutyryl cyclic AMP 
stimulate ketone bodies synthesis through a cyclic AMP-mediated mechanism 
independent from variations in circulating free fatty acids. As said before, HGM-
CoA synthetase is inhibited by succinyl CoA, which occupies a site normally 
filled by acetate. The reverse reaction of the inhibition is quite slow and favoured 
by acetyl CoA. This process provide an additional mechanism whereby an 
increase in acetyl CoA might activate ketone bodies synthesis and it can also 
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give an explanation for the direct glucagon effect, since this hormone reduces 
the concentration of succinyl CoA in the liver. It is largely accepted that ketone 
bodies synthesis can be activated by a rise in mitochondrial acetyl CoA levels, 
which is definitively a consequence of hormonal stimulation of lipolysis in 
adipose tissue and a fall in succinyl CoA, that results from a direct effect of 
glucagon on the liver cells (Nguyen et al, 2007). 
 
1.4 Oxidative stress in fish 
 
Many stresses that are induced by the environment frequently activate the 
endogenous production of reactive oxygen species (ROS), the majority of which 
are generated as side products of tissue respiration. As a consequence, a 
continuous exposure to stressors may enhance ROS-mediated oxidative 
damage. Oxidative stress can be defined as a situation in which steady-state 
ROS concentration is transiently or chronically enhanced, disturbing cellular 
metabolism and its regulation, damaging cellular constituents (Lushchak, 2011). 
The activation of oxidative manifestations leads to the response of antioxidants, 
activation of expression of genes which encode antioxidant enzymes and 
elevation of the concentration of ROS scavengers. Oxidative stress occurs 
when the ROS generation rate exceeds that of their removal (Sies, 1986). Its 
deleterious effects include oxidation of proteins, DNA and steroid components, 
as well as peroxidation of unsaturated lipids in the cell membrane. All that 
produces unstable lipid hydroperoxides, the products of which, decomposing, 
are highly reactive. These products can also break down into free radicals that 
can continue the destructive cycle of lipid peroxidation by chain reactions. 
Biological oxidation is a primitive process and, in the face of the inevitable 
consequences of O2 toxicity, evolution has provided appropriate defensive 
strategies. The first line of defense is the employment of antioxidant substances, 
such as vitamin C, vitamin E, uric acid, glutathione and carotenoids. In addition, 
different antioxidant enzymes prevent the cascade of oxidant reactions, 
intercepting and inactivating the reactive intermediates of oxygen, concluding 
the lipid peroxidation cycle. Antioxidant enzymes are crucial in the effort to 
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counteract oxygen toxicity when the supply of other antioxidant compounds is 
scarce or depleted (Ahmad, 1995). Like all aerobic organisms, fish are 
susceptible to be attacked by ROS and have developed antioxidant defenses. 
Specially adapted enzymes, such as catalase, superoxide dismutase and 
enzymes dependent on glutathione (glutathione peroxidase and glutathione 
reductase) have been found in most fish species (Rudneva, 1997). Together 
with these enzymes, lower-molecular-weight antioxidants, such as carotenoids, 
vitamins E, K and C, amino acids and peptides (glutathione) have been 
detected as antioxidant defenses in fish. Differently from the model of oxidative 
stress that is usually caused by singular substances acting under controlled 
laboratory conditions (concentration and period) (Bagnyukova et al., 2005, 
2006, 2007; Kubrak et al., 2010; Lushchak et al., 2007, 2008, 2009 a, b, c; Yi et 
al., 2007; Sun et al., 2008), environmental impact is usually developed 
according to multiple stressor effects. In fact, ecosystems are under the 
pressure of complex mixtures of contaminants released to the environment, due 
to different human activities. They can originate from miscellaneous sources, 
which might be chemical and drug manufactures, domestic sewage, polymer 
and petrochemical-based industries, oil refineries, mining, glass blowing, battery 
manufacture and many others. Hydrological changes, hydromorphological 
degradation and invasive species can also contribute to the set of stressing 
factors (Amado et al., 2006; Sureda et al., 2006; dos Anjos et al., 2011). As a 
consequence of all these factors, aquatic environment is a sink for many 
environmental contaminants that can be absorbed by aquatic organisms leading 
to the disturbance of antioxidant/prooxidant balance in fish (Lackner, 1998; 
Livingstone, 2001; Lushchak, 2011). Synergistic or antagonistic effects of 
mixtures of pollutants are hardly interpreted and predicted exclusively from the 
chemical analyses. Some contaminants are substantially stored in specific 
tissues without recorded toxic effects (Viarengo and Nott, 1993), while others 
produce high toxicity even at low levels. For this cause, oxidative stress 
response of fish cannot be predicted using data on the level of certain pollutants 
in their tissues. Basing on the intensity and duration of toxicant effect and 
resistance of many studied organisms, different manifestations of oxidative 
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stress can be expected. The long-term effects of pollutants, typical for 
chronically and heavily polluted areas, the increase of ROS levels and 
perturbation of antioxidant efficiency often prelude the starting of significant 
alterations like proteins and DNA damage, lipid peroxidation and enzyme 
inhibition (Winston and Di Giulio, 1991). Fish are particularly threatened by 
aquatic pollution and the environmental stress they have to face may help to 
constitute their ecology, evolution or biological systems (Padmini, 2010). The 
expression of specific damage known to be caused specifically by oxidative 
stress (e.g. lipid peroxidation and membrane lesions, oxidized bases in DNA 
and accumulation of lipofuscin pigments) were found in many aquatic animals 
exposed to contaminants (Winston, 1991). The end-products of lipid 
peroxidation/oxidation (LPO) can be accumulated in lysosomes as insoluble 
granules containing autofluorescent pigments and are usually referred as 
lipofuscin. The presence of these pigments in the lysosome vacuolar system of 
fish hepatocytes can be also used for the assessment of the level of membrane 
LPO (Viarengo et al., 2007). In any case, whilst in the laboratory a wide 
spectrum of the previously mentioned effects can be measured, only a single 
parameter is often analyzed in Environmental Risk Assessment. Hence, the rate 
of oxidative damage is the control point of the effective adaptation to oxidative 
stress. 
LPO usually measured as level of thiobarbituric acid reactive substances 
(TBARS), has been used very often to analyse the effects of pollutants 
(Livingstone, 2001; Lushchak et al., 2007, 2008, 2009 a, b, c, 2011). The big 
amount of LPO in fish from heavily polluted field sites was observed (Ferreira et 
al., 2005; Farombi et al., 2007; Sanchez et al., 2007) and an example of this can 
be referred to the African catfish (Clarias gariepinus) from the Ogun River 
(Nigeria), in which TBARS levels resulted significantly higher in the liver, kidney, 
gills and heart compared to those from fish farmed of the same species, which 
were considered as a reference site (Farombi et al., 2007). The formed free 
radicals cause various kinds of genotoxicity, especially modifications to DNA 
bases. The majority of the analytical assays have been focused on measuring 
products of guanosine hydroxylation, namely 8-OHdG or 8-oxodG, and its free 
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base 8-hydroxyguanine in urine as an indirect method for oxidative damage by 
free radicals (Shigenaga and Ames, 1991). A study with the fish gilthead sea 
bream found that 8-oxodG determination in chromosomal DNA was a potentially 
useful biomarker of oxidative stress caused by urban and industrial 
environmental pollution (Rodriguez-Ariza et al., 1999).  
Proteins are considered to be important targets of free radicals attack in cells 
(Eustace and Jay, 2005; Almroth et al., 2008 b; Lushchak, 2011) and thus, 
compromise antioxidant defense, cellular function and survival (Padmini, 2010). 
Therefore, protein oxidation, often under investigation in proteomic studies, has 
been recently proposed as a biomarker of oxidative stress (Sheehan, 2006; 
Lushchak, 2011).   
 
1.5 Antioxidant compounds and PPARs receptors 
 
In recent years, the addition of natural substances with antioxidant properties is 
an emerging strategy for protecting biological systems and foodstuffs from 
oxidative damage. Tea catechins (He and Shahidi, 1997), grape 
proanthocyanidins (Pazos et al., 2006), rosemary extracts (Medina et al., 2003) 
and hydroxytyrosol (HT) extracted from olive oil (Pazos et al., 2008) have 
demonstrated elevated potential to inhibit lipid oxidation in fish muscle-based 
food products. Among the natural substances, hydroxycinnamic acids, including 
caffeic (Caf-OH), ferulic, o-coumaric or chlorogenic acids have also attracted 
considerable attention as food antioxidant additives due to their potential 
biological and antioxidant activities (Nardini et al., 1995). In particular, 
chlorogenic acid inhibits carcinogenesis in the colon, liver and tongue and also 
protects against oxidative stress in vivo (Mori et al., 1986; Tanaka et al., 1993; 
Tsuchiya et al., 1996). Chlorogenic acid has been claimed to modulate the 
glucose-6-phosphatase involved in glucose metabolism (Hemmerle et al., 1997) 
and to reduce the risk of cardiovascular disease by decreasing oxidation of low- 
density lipoproteins (LDL), cholesterol and total cholesterol (Nardini et al., 
1995). More recently, it was reported that chlorogenic acid inhibites 
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preadipocyte population growth, which may provide a proposed mechanism for 
reducing obesity (Hsu et al., 2006). 
Caf-OH and in general o-dihydroxyphenolics, can protect lipids from oxidation 
by at least two well-described mechanisms: 1) scavenging free radicals as a 
primary antioxidant method and 2) chelating active transition metals to form 
inactive metallic complexes (Frankel, 1998). 
Many experiments with the polyphenols demonstrated substantial modulation of 
physiological and molecular pathways involved in energy metabolism and 
adiposity (Meydani and Hasan, 2010). Catechins from green tea (Lin et al., 
2005), resveratrol from red grapes (Floyd et al., 2008) and curcumin from 
curcuma (Ejaz et al., 2009) suppressed adipogenesis on the 3T3-L1 cell line 
through several mechanisms including attenuation of peroxisome proliferator-
activated receptor γ (PPARγ) regulatory pathway (Manach et al., 2004). Also 
the olive tree (Olea europaea) and its products are a source of at least 30 
phenolic compounds and, particularly, extra-virgin olive oil contains 
considerable amounts of phenolic compounds, such as oleuropein (OL) and the 
product of its hydrolysis, HT. In vitro, OL reduced the expression of PPARγ, 
inhibithed adipogenesis and enhanced osteoblastogenesis in stem cells derived 
from human bone marrow (Santiago-Mora et al., 2011). It was seen that OL, in 
concentration higher than 100 µM, acted on the 3T3-L1 cells to reduce 
preadipocyte differentiation and lipid storage regulating the size of fat cells. OL 
between 10 and 400 µM concentrations did not affect activity of PPARα or 
PPARβ/γ. Contrary, PPARγ activity, either basal or rosiglitazone activated, was 
inhibited by OL. Some datas suggest that OL exerts anti-adipogenic effect 
through direct inhibition of PPARγ transcriptional activity. The expression of key 
transcriptional modulators of adipocyte differentiation genes PPARγ, CCAAT-
/enhancer binding protein a (C/EBP1a), the sterol regulatory element binding 
transcription factor 1c (SREBP-1c) and their downstream target genes were 
suppressed by OL in a dose dependent way during the process of differentiation 
(Drira et al., 2011). 
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It has been shown that HT is highly efficient to prevent oxidation in fish oils, fish 
oil in water emulsions and fish fillets (Pazos et al., 2008). This is particularly 
interesting for stabilizing functional products containing ω-3 PUFA. In addition, 
HT has exhibited very interesting biological properties, such as inhibition of 
human LDL oxidation, a critical step in atherosclerosis, (Visioli et al., 1995), 
inhibition of platelet aggregation (Petroni et al., 1995), anti-inflammatory (de la 
Puerta et al., 1999) and also anticancer properties (Owen et al., 2000). HT is 
strongly hydrophilic and this property makes difficult its incorporation into fats 
and oils. It has been reported that both OL and HT are able to exert apoptotic 
effects in human MCF-7 BC cell line (Han et al., 2009). In addition, it has been 
recently demonstrated the ability of HT and OL to inhibit MCF-7 BC cells 
proliferation through a mechanism that does not involve a classic estrogen 
receptor-mediated gene regulation but an ERK 1/2 (Extracellular Regulated 
Kinase 1 and 2) activation (Sirianni et al., 2010). This last observation lets 
hypothesize that the inhibitory effect exerted by the two phenols might be 
attributable to their ability to interfere with a non-genomic action of estrogen. 
Since their initial discovery as transcription factors, which were activated by a 
variety of chemical and pharmacological compounds known to induce 
peroxisome proliferator factors in rodents (Issemann and Green, 1990), PPARs 
have been intensively studied in humans and rodents and have been the 
subjects of many reviews (Desvergne et al., 2004; Hihi et al., 2002). PPARs are 
ligand-activated nuclear hormone receptors acting as heterodimers with retinoid 
X receptors (RXR). PPAR/RXR heterodimers bind to DNA sequences that 
consist of the nucleotide repetition AGGTCA separated by one base pair (DR1 
sequence).  
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Fig. 7. PPARs structure and pathway. PPRE= Peroxisome Proliferator 
Response Element (Source: hindawi.com; journals.prous.com). 
 
The PPAR/RXR heterodimers are considered ‘’permissive’’ complexes because 
they can be activated either by PPAR ligands or by RXR ligands. In mammals, 
were found three genes encoding PPARs: PPARα, PPARβ (or δ) and PPARγ. 
These genes have different tissue expression profiles that, along with the tissue 
specific expression of co-repressor and co-activator proteins and diversities in 
ligand selectivity, determine their action in regulating genes involved in fatty acid 
homeostasis (Desvergne et. al., 2006). All mammalian PPARs bind and are 
activated by unsaturated fatty acids, even though a variety of multitude of 
oxidized derivatives of fatty acids, such as eicosanoids, have higher affinity and 
are also more subtype specific. This fact, has led to the thought that PPARs are 
general fatty acid sensors that respond to increased cellular fatty acid levels or 
 30 
their metabolites, which result in changes in nutritional status and energy 
metabolism (Michalik et al., 2006). Because of their important functions in fatty 
acid metabolism, PPARs have also been the subject of many studies in fish, 
including Atlantic salmon and sea bream. PPARγ is encoded by a single gene in 
mammals that, through alternative splicing, gives rise to two proteins, PPARγ 1 
e PPARγ 2, with distinct N-terminal sequence (Tontonoz et al., 1994). The 
second one is highly expressed in adipose tissue, whereas PPARγ 1 is 
expressed to a high level in gut and at a lower level in a variety of other tissues 
too (Escher et al., 2001). Mammalian PPARγ is essential for fat storage, 
especially in adipocytes, but also in lipid accumulating macrophages (Rosen et 
al., 1999; Fajas et al., 2001). PPARγ was the first subtype to be identified in fish, 
with cDNAs characterized from Atlantic salmon and plaice (Ruyter et al., 1997; 
Leaver et al., 1998). After that, the availability of genome information for 
zebrafish, stickleback, medaka and pufferfish has shown that, similarly as in 
mammals, these fish possess a single PPARγ gene, such as other studies on 
sea bream, sea bass and plaice also indicate the presence of a single gene 
(Maglich et al., 2003; Boukouvala et al., 2004; Leaver et al., 2005). There are no 
available indications yet of alternatively spliced products and thus alternative 
PPARγ proteins in fish. Either fatty acid or mammalian PPARγ-specific ligand 
fail to activate sea bream or plaice PPARγ (Leaver et al., 2005) and, at the 
same time, Atlantic salmon PPARγ is unresponsive to typical mammalian 
PPARγ agonists (Leaver et al., unpublished). Even though fish PPARγ is an 
evident homologue of mammalian PPARγ, all PPARγ proteins of fish identified 
up to now have a critical amino acid substitution, in which a tyrosine residue in 
all mammalian PPARs and essential for binding the carboxylic head group of 
fatty acids and synthetic ligands is substituted by a methonine. This fact 
suggests the idea that fatty acids and synthetic ligands are not able to activate 
PPARγ of fish (Leaver et al., 2005; Maglich et al., 2003). In this case, is likely 
that piscine PPARγ is activated by unidentified compounds, even if, because of 
its similarity with the entire structure of mammalian PPARγ, these unidentified 
compounds are probably related to fatty acids.  Many differences between 
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mammalian and PPARγ of fish are also evident from tissue expression profiles. 
It was seen that PPARγ is expressed at a high level relative to other PPARs 
and, differently to mammalian PPARγ, in a wide range of sea bream and plaice 
tissues (Leaver et al., 2005). In addition, the expression of sea bream hepatic 
PPARγ mRNA levels increase upon feeding, whereas in adipose tissue they 
remain constant. It was also observed in rainbow trout that the gene 
transcription levels of PPARs changed differentially during fasting and refeeding 
and that tumoral necrosis factor α (TNFα) and/or lipopolysaccharide 
administration suggested the idea that the regulation of PPARs helps maintain 
metabolic adipose tissue homeostasis. In mammals and, as it would appear, in 
fish, PPARγ is highly expressed in adipose tissue and acts as a promoter of fat 
storage and adipocyte differentiation (Bouraoui et al., 2008; Cruz-Garcia et al., 
2009; Yin et al., 1998). It was found that insulin administration upregulated 
PPARγ isotype highly significative in trout adipose tissue and in vitro cell 
preparations, in line with the prolipogenic actions of this hormone. Similarly, the 
presence of insulin during trout adipogenesis induced preadipocyte 
differentiation and lipid accumulation, which occurred together with an increase 
in PPARγ protein levels (Bouraoui et al., 2008).  At this point, the identification 
of agonists for piscine PPARγ is a necessary step for further studies. 
A variety of environmental contaminants are agonists of the PPARs. In sensitive 
rodent models, it was observed that chronic exposure to PPAR-active 
substances causes cellular peroxisome proliferation, elevates enzymatic 
markers of oxidative stress and it is linked to the development of hepatic tumors 
(Gervois et al., 2000; Suga et al., 2004). Peroxisome proliferation is now 
recommended as a biomarker of exposure to PPAR-active compounds in 
environmental pollution assessment (Cajaraville et al., 2003). Many compounds 
that are known PPAR agonists are contaminants in the aquatic environment, 
including phthalate plasticizers (McDowell et al., 2001) and fibrate drugs 
(Metcalfe et al., 2003). These compounds could affect the health of aquatic 
organisms, including fish, and a number of studies report that fish respond at 
the cellular level to PPAR agonists (Donohue et al., 1993; Scarano et al., 1994). 
Detection of PPAR-active substances using analytical techniques, such as liquid 
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chromatography-mass spectrometry, is expensive and time consuming, so that 
cell-based reporter gene assays represent alternative methods to detect PPAR-
active substances. Reporter gene assays with fish cells have been also 
developed to determine the presence of estrogenic substances in the 
environment (Petit et al., 1997; Ackermann et al., 2002). Thiazolidinediones 
(TZDs) are a group of PPARγ agonists, a class of anti-diabetic drugs, which 
include rosiglitazone (RGZ) and pioglitazone. The activation of PPARγ by TZDs 
leads to the redistribution of fat from visceral to subcutaneous adipose tissue, 
increased trapping of fatty acids in adipose tissue and a modified secretion of 
hormones from adipose tissue; all factors known to improve insulin sensitivity 
(Semple et al., 2006). Anyway, administration of TZDs has been associated with 
unexpected side effects such as weight gain, edema, and hepatotoxicity (Guan 
et al., 2005; Pan et al., 2006). 
Recently, identification of new PPARγ partial agonists that do not present the 
adverse side effects caused by PPARγ full agonists have received considerable 
attention for developing powerful drugs against diabetes. The ligands acting as 
partial agonists induce submaximal receptor activation and have been 
demonstrated to retain beneficial anti-diabetic properties with reduced side 
effects. Despite the lower activation of the receptor, they are still able to induce 
PPARγ target genes responsible for anti-hyperglycemia and insulin sensitivity, 
but not for the unwanted PPARγ actions (Bhalla et al., 2011; Agrawal et al., 
2012). The reason for this is not entirely understood. 
 
 
 
 
 
 
 
 
 
 33 
1.6 Objectives 
 
Fat loss may be normally caused by two main processes: enhancement of 
lipolysis and inhibition of triglycerides accumulation. In mammals, it has been 
demonstrated that CA and HT inhibit adipocytes differentiation and thus lipid cell 
content, reducing the activation of PPARγ (Juman et al., 2010; Warnke et al., 
2011). However the potential lipolytic effect of these compounds remains 
unclear. It is commonly known that PPARγ regulates adipocytes differentiation 
and the subsequent accumulation of cytoplasmic lipid droplets. Moreover, RGZ 
is a PPARγ agonist that regulates genes involved in lipid metabolism and 
homeostasis. It has been confirmed that RGZ has a clear effect in stimulating 
adipocytes hypertrophy in zebrafish (Tingaud-Sequeira et al., 2011). 
 
In this frame work, the major aims of the present study are using rainbow trout 
as model:  
1) to determine the effect of an intraperitoneal injection of CA and HT on lipid 
metabolism and oxidative stress related genes in liver and adipose tissue;  
2) to define the effect of an in vitro incubation of CA and HT on lipid metabolism 
in primary cultured adipocytes;  
3) to describe the potential anti-adipogenic effect of CA and HT, analyzing the 
effects of these compounds on viability, proliferation and differentiation in 
rainbow trout primary cultured adipocytes;  
4) to describe how CA and HT can interfere with PPARγ gene expression in 
primary cultured adipocytes, by immunofluorescence analysis for PPARγ. 
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 2. Material and methods 
 
2.1 Animals 
 
Juvenile (intraperitoneal experiments) and adult (cell cultures) rainbow trout (O. 
mykiss) weighing between 80 and 250 g respectively were maintained either in 
0.2 m3 and 0.4 m3 tanks with a temperature-controlled freshwater recirculation 
system (18 ± 1°C) and 12 hours light/12 hours dark photoperiod. All animal 
handling procedures were approved by the Ethics and Animal Care Committee 
of the University of Barcelona, following the regulations and procedures 
established by the EU, and by the Spanish and Catalan governments (permits 
reference numbers CEEA 237/12 and DAAM 6755). The trouts were fed daily at 
will with a commercial diet (Skretting).  
 
2.2 Intraperitoneal injections 
 
After 15 days of acclimation, animals used in intraperitoneal injection were 
fasted from 2 h before the injection to 24 h post-injection (26 h) when sampling 
was carried out. Juvenile fish were anesthetized with ethyl 3-aminobenzoate 
methanesulfonate (MS-222 0.1 g/L) and received intraperitoneal injections of 
4.64 µL of volume per g of body mass of the different treatments. Treatments 
were diluted 1:3 in sesame oil as follows: 1) control containing dimethyl 
sulfoxide (DMSO) diluted in sesame oil; 2) CA at 10 µg/g and 3) HT at 20 µg/g 
(n = 9). After 24 h, fish were first anesthetized and then sacrificed by a sharp 
blow to the head; after that, their masses were recorded and blood samples 
were taken from the caudal aorta. Samples of liver and perivisceral adipose 
tissue were harvested and stored at -80°C until analysis.   
 
 
 
 
 35 
2.3 Cell culture 
 
To avoid contamination from the gastrointestinal tract, adult fish were fasted 24 
hours before the experiments. The cell culture procedure was performed as 
described in Bouraoui et al., 2008. After counting, cells were seeded (800.000 
cells in 2mL or 400.000 cells in 1 mL) in gelatin pre-treated six-wells or twelve-
wells plates (9.6 cm2/well or 2.55 cm2/well respectively) and kept at 18°C with 
growth medium. After confluence (day 7), cells were induced to differentiate by 
means of incubation with a growth medium supplemented with 10 µg/mL of 
insulin, 0.5 mM of 3-isobutyl-1-methylxanthine (IBMX), 0.25 µM of 
dexamethasone and 10 µL/mL of lipid mixture. Media were changed every two 
days during the whole procedure. 
 
2.3.1 Reagents preparation 
 
• Krebs: 
 
Prepare 500 mL of stock Krebs (x10) solution the day before starting the culture,  
aliquot it in the same solution in identical parts of 50 mL and, finally, freeze it. 
The following amounts are for trout culture: 
 
Reagents Concentration (mM) x 500 mL  (g) (x10) 
NaCl 117.5 34.33 
KCl 5.6 2.09 
CaCl2 (dehydrated) 2.52 1.85 
MgSO4 1.18 1.45 
NaH2PO4 
(monohydrated) 
1.28 0.88 
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The day of cultivation prepare 500 mL of working solution (Krebs x1) and agitate 
it with a magnet inside. 
 
Reagents Amounts 
Stock Krebs (x 10) 50 mL 
Distilled water or Milli Q 445 mL 
NaHCO3 (25 mM) 1.05 g 
D-glucose 0.495 g 
HEPES pH 7.4 5 mL 
 
 
• HEPES (1M, pH=7.4) 
 
• Erythrocyte buffer: 
 
Prepare 100 mL of solution at pH 7.3 and putting it into the autoclave/steamer. 
 
Reagents x 100 mL (g) 
NH4Cl 0.822 
KHCO3 0.101 
EDTA 0.0292 
 
• Collagenase: 
 
Prepare collagenase Type II sigma C6885 (130 U/mL) according to the formula 
below. Filter collagenase with a 0.22 µm filter (Millipore CatN° SVGP01050). 
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(130 U/mL) x (mg/475 U of collagenase) x (mL of Krebs buffer to add)= 
X mg collagenase in X mL of Krebs bovine serum albumin (KBSA) 1%. 
 
475= collagenase units written on the bottle. 
mL of Krebs buffer= volume of Buffer Krebs to add, depending on the amount of 
tissue (1g/5 mL). 
 
• Medium of growth: 
 
These amounts are to prepare 500 mL of medium: 
 
Reagents Amounts 
Feral bovine serum (FBS, Sigma 
F7524-500 mL) 
50 mL 
Antibiotic (1%) (mix Sigma A5955-
100 mL) 
5 mL 
L-15 (Leibovitz’s Ref. 11415) Add to complete the volume 
 
• Medium of differentiation (x 50 mL): 
 
- Insulin (I5523, Sigma; PM 5807 g)⇒ 171.87 µL (to keep into the freezer) 
 
- Dexametasone (4°C, D2915, Sigma 1mM into water; PM 392.5 g)⇒ 12,5 µL 
 
- IBMX (-20°C, 17018, Sigma stock 1M in DMSO; PM 222,25 g)⇒ 50 µL 
 
- Lipids (L5146, Sigma 4°C)⇒ 250 µL (to keep into the freezer) 
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• Gelatin 1%:  
 
Gelatine dust must be sterile, so that it must be used inside the hood. A definite 
amount of gelatin (1.5 g of gelatin + 150 mL of distilled water) can be used 
outside the hood but, after the preparation, it has to be autoclaved. 
 
• Feral Bovine Serum (FBS): 
 
FBS is at the liquid state and it is stored (in aliquots of 30 mL) into the freezer at 
-20° C.  
 
2.3.2 Procedure 
 
The day before culture 
 
Keep out of the freezer the FBS and the stock Krebs (x 10). Keep the plates 
inside the aspirant hood with gelatin 1% (1 mL per well). Put the plates into the 
incubator at 18°C for three h; then wash them twice (500 µL/well) with antiseptic 
phosphate Buffered Saline(PBS). At the end, put the PBS in the each well again 
and store the plates into the incubator at 18°C. 
 
The day of culture 
 
Prepare 500 mL of Krebs-HEPES solution and mix it with CO2 5% for 7 min.  
Weight 0.5 g of the anaesthetic compound MS-222 and filter about 370 mL of 
Krebs-HEPES solution. Put 5 mL for each of Krebs-HEPES filtered solution plus 
50 µL of antibiotic into 4 falcons.  
 
Anesthetize 3-5 trout with MS-222 and kill them by a blow to the head. After 
that, weigh the fishes and extract 20 g of adipose tissue from them (5 g of tissue 
for each falcon). Add 28,13 mg of collagenase to the Krebs-HEPES solution 
plus 1% of BSA. Then filter the collagenase inside the Krebs-HEPES solution.  
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Add the content of each falcon into a Petri plate and mince the adipose tissue 
with two scalpels. Put the minced tissue in two new falcons, add 5 mL of 
collagenase in Krebs-HEPES solution in each falcon and put them inside the 
incubator for 1 h at 18°C.  After that, integrate the volume of the two falcons to 
50 mL with Krebs-HEPES solution and centrifuge at 1500 rpm and 4°C for 10 
min. After the use of centrifuge, collect just the precipitated part inside the 
falcons (the pre-adipocytes + the erythrocytes) and add 5 mL of erythrocyte 
lysis buffer to each falcon for no more than 10 min, so that the precipitated part 
will dilute into the buffer solution. Add the content of two falcons into a new one 
with the help of a suitable filter.  
 
Wash the empty falcons with 5 mL of Krebs-HEPES solution, from the first 
filtration procedure, and transfer the content to the washed falcon with a specific 
filter, avoiding the floating part made of adipocytes. Add to the previous falcons 
Krebs-HEPES solution until reaching the volume of 35 mL. Put again the falcon 
into the centrifuge at the same condition, before mentioned. After this last step, 
remove the floating part of the centrifuged falcon and add 1 mL of growth 
medium. 
 
The following step is the cell count; to do this collect and mix: 20 µL of pre-
adipocytes, 10 µL of growth medium and 10 µL of trypan blue, a colorant. Get 
20 µL of the previous solution and put it into a Neubauer chamber, made of 4 
squares. Count the cells inside the 4 squares and calculate an arithmetic mean 
of the numbers expected for each square.   
 
Day following to culture 
 
Put 500 µL of L-15 inside every well and observe the plates by the microscope. 
We are interested in gray cells with a fibroblastic shape and not to round, 
glittering cells. 
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Remove L-15 from the plates and put 500 µL of growth medium in each well. 
Then, close the plates. 
Replace the growth medium every 2 days approxymately.   
 
Differentiation 
 
When the cells flow together and become confluent, add the differentiation 
medium. 
 
2.4 MTT proliferation assay  
 
MTT is a colorimetric assay which allow us to determine an enzymatic activity 
because of a change in colour. This assay is based on metabolic reduction of 
Bromide 3-(4,5-dimetiltiazol-2-ilo)-2,5-difeniltetrazol (MTT) (a water solvable salt 
of yellow colour), performed by the mitochondrial enzyme succinate-
dehydrogenase in a light blue compound (fomazan), allowing to determine 
mitochondrial functionality of treated cells. MTT method is very useful to analyze 
survival and proliferation of cells. The amount of living cells is proportional to 
abundance of formazan produced. Metabolized MTT in formazan forms water 
insoluble crystals which remained trapped into the cells and they have to be 
solved into organic dissolvent, such as dimethylsulfoxide (DMSO), before doing 
colorimetry. This method was realized by Mosmann in 1983 and it was modified 
in 1986 by François Denizot and Rita Lang.  
 
MTT Stock solution  
 
Add 5 mg of MTT (Ref. M5655 500 mg, Sigma) per mL of PBS (Phosphate 
Buffered Saline). MTT stock solution must be stored covered in aluminum paper 
at 4°C because it is sensitive to light, so a possible degradation of this might 
cause false positive results. MTT stock solution, when it is stored, lasts 
approximately one month. 
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MTT treatments 
 
At day 5 of cell culture (cellular proliferation), the following treatments were 
tested: 
 
1. Control (Growth medium+DMSO) 
 
2. CA 50 µM  
 
3. HT 100 µM 
 
4. RGZ 1 µM 
 
5. CA 50 µM + RGZ 1 µM 
 
6. HT 100 µM + RGZ 1µM 
 
The initial concentration of the compounds used in the treatments were the 
same for all in vitro experiments and were the following: CA=10 mM, HT=10mM 
and RGZ=100 µM. After 24 h of incubation, the MTT protocol can be applied. 
 
MTT protocol 
 
1. Put 50 µL of MTT stock solution into every single well + 450 µL of 
differentiation medium (for a 12 wells plate) or 100 µL + 900 µL (for a 6 
wells plate), in the way of covering the complete surface of each well. 
Besides, a single well is used as control, so that it is added PBS instead of 
MTT. 
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2. Keep the plate with MTT inside the incubator over night, in the case of 
adipocites. At the moment of keeping out of the incubator the MTT 
solution, we should observe many light blue crystals by the microscope. 
 
3. Wash once every well of the plate with 1 mL of PBS solution. 
 
4. Add 150 µL (for a 12 wells plate) or 250 µL (for a 6 wells plate) of DMSO 
(Dimethylsulfoxide) to dissolve the pre-formed crystals. After that, store 
the MTT plate into the incubator for two h. 
 
5. Put 100 µL of the solution from every plate (for a 12 wells plate) or 200 µL 
(for a 12 wells plate) inside an ELISA plate to mesure the absorbance at 
570 nm and at 650 nm by a TECAN plate spectrophotometer. The 
formazan solution absorbs the light at 570 nm but not at 650 nm; for this 
reason the final optical density (OD) obtained from the formazan can be 
calculated as the difference between 570 and 650 nm absorbances.  
 
6. To the obtained OD values, the OD value from the ‘’control’’ well 
containing PBS solution has to be subtracted. At the end, the data can be 
normalized compared with one of the treatment (‘’control’’ situation). 
 
2.5 ORO coloration and triglycerides (TG) quantification 
 
Oil Red O (ORO) is a technique useful to demonstrate the presence of fat or 
lipids in fresh and/or frozen tissue sections. ORO was introduced by French in 
1926 and it is a fat-soluble diazo dye, classified as one of the Sudan dyes which 
have been in use since the late 1800s. ORO is not a true special stain, since 
it can not form bonds with lipid components but it is actually a pigment that 
functions as an oil-soluble colorant; so this technique represents a physical 
method of staining. The basis for staining lipids with an oil-soluble dye is due to 
its increased solubility in fatty substances, differently from the dye solvents 
which are used in routine tissue processing, and propylene glycol is the 
 43 
preferred solvent for this technique. The end result is that fat and lipids in tissue 
sections stain bright red (Fig. 8). 
 
 
      
 
Fig. 8. Picture of adipocytes treated with Oil Red O coloration at day 14 taken 
by an Olympus optical microscope. 
 
ORO treatments 
 
At day 7 of the cell culture (starting of the cellular differentiation), the following 
treatments were applied: 
 
1. Control (Differentiation medium + DMSO) 
 
2. RGZ 1 µM 
 
3. RGZ 1 µM + CA 50 µM 
 
4. RGZ 1 µM + HT 100 µM 
 
5. Lipid 
 
6. Lipid + HT 100 µM 
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7. Lipid + CA 100 µM 
 
After 72 h the ORO protocol can be applied. 
 
Coloration of TG 
 
Stock Solution ORO 
 
• 500 mg ORO/100 ml of 60% TEP (Triethyl phosphate). 
 
• Dilute 12 ml of stock solution with 8 ml of water. 
 
• Filter with paper Whatmann (n. 4). 
                                               
 
                     Working Solution ORO (in 36% TEP) 
 
 
1. Wash the cells with PBS. 
 
2. Fix the cells with 3.7% formaldehyde for 1 h. 
 
3. Wash three times with wáter for 30 s. 
 
4. Color the cells with Working solution ORO for two h. 
 
5. Wash three times again with water for 30 s. 
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TG extraction 
 
• Dry cells completely. 
 
• Add isopropanol: 250 µl for plate of 6 wells or 150 µl for plates of 12 wells 
for 30 min. 
 
• Put in 100 µl x 2 for plates of 6 wells or 100 µl for plates of 12 wells in an 
ELISA plate at 490 nm (TECAN). 
 
• Add water and let the plate rest overnight. 
 
Coloration and proteins extraction 
 
• Wash twice with distilled water. 
 
• Add 1 ml of Comassie blue solution for 1 h at room temperature. 
 
• Wash twice again with distilled water. 
 
• Add propylene glicol: 1 ml for plates of 6 wells or 500 µl for plates of 12 
wells and for 1 h incubate at 60°C. 
 
• Put in 100 µl x 2 for plate of 6 wells or 100 µl for plates of 12 wells and 
analyse by an ELISA plate at 630 nm (TECAN). 
 
Calculation TG/proteins: simply divide the OD of 490/630 nm. 
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2.6 Immunofluorescence  
 
Immunofluorescence is a technique primarily used on microbiological samples. 
It is based on the specificity of antibodies to their antigen to identify a specific 
target biomolecule with a fluorescent dye, called fluorophore or fluorochrome, 
allowing the visualization of the distribution of the target molecule through the 
sample. Immunofluorescence can be used in tissue sections, cultured cell lines 
or individual cells and may be used to analyze the distribution of proteins, 
glycans and small biological and not biological molecules. Indirect 
immunofluorescence relies on two antibodies: the primary antibody and the 
secondary antibody. The first one detects and joints to a target molecule while 
the second one, marked with a molecule of fluore, identifies the primary 
antibody and binds to it. The fluorophore allows visualization of the target 
distribution in the sample under an epifluorescent or a confocal microscope. 
 
Immunofluorescence treatments 
 
The following treatments were put at day 7 of cell culture: 
 
1. Control (Differentiation medium+DMSO) 
 
2. RGZ 1 µM 
 
3. Lipid 
 
4. RGZ 1 µM + HT 100 µM 
 
5. RGZ 1 µM + CA 50 µM 
 
6. Lipid+HT 100 µM 
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7. Lipid+CA 50 µM 
 
Immunofluorescence protocol was applied after 72 hours. 
 
Reagents 
 
- PBS (Phosphate Buffered Saline). 
 
- PFA (Paraformaldehylde 4% solution, pH 7.4). 
 
- Triton X 100 (humectante to permeabilize). 
 
- BSA (Albumine Bovine Serum) at 4°C. 
 
- Tween 20 (Polyoxythylenesorbitan monolaurate detergent). 
 
- Prolong (fixation of coverslip on the glass slide). 
 
- HOECHST or DAPI (nucleus colouring). 
 
Solutions attainment 
 
PBS solution 1M at pH 7.4 (x 250 mL of solution): 
- 31.15 g of Na2HPO4 2H2O. 
- 11.70 g of NaH2PO4 2H2O. 
Dilute in milliQ sterile water, adjust the pH at 7.4 and complete the volume at 
250 mL. 
 
PFA 4% solution/PBS (x 250 mL of solution): 
- 10 g of PFA. 
- 225 mL of milliQ water. 
- 25 µL of NaOH. 
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PFA solution must be heated up to 65°C, until it becomes transparent, under a 
specific hood for gases extraction because of the toxicity of the solution. As 
soon as the solution becomes colder, just add 100 mL of PBS at pH 7.4. 
 
PBS solution/Triton x 100 0.2%: 
 
In 100 mL of PBS add 200 µL of Triton x 100 and store the solution at 4°C. 
 
PBS solution/Tween 20 0.1%: 
 
In 100 mL of PBS add 100 µL of Tween 20 and store the solution at 4°C. 
 
BSA solution 3%/Tween 20 0.1%: 
 
In 100 mL of PBS-Tween 20 0.1% add 3 g and store the solution at 4°C. 
 
Procedure 
 
Fixing 
 
1. Take out the plate from the incubator and do two washes with PBS 
solution (remove the medium from the wells and add 0.5 mL of PBS to 
each well until its total coverage). 
 
2. Add 0.5 mL of PFA 4%/PBS to each well, or another amount until covering 
each well totally, for 30 minutes at room temperature. 
 
3. After 30 min, wash three times with PBS for 5 min. At the last wash with 
PBS, leave the solution inside the wells and store the plate at 4°C for a 
week. 
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Permeabilization 
 
1. Remove PBS from the wells and add 0.5 mL of BSA solution 3%/Tween 
20 at 0.1% during 1 h. 
 
2. Wash once with PBS for 5 min (add 0.5 mL into each wells for a 12 wells 
plate).  
 
Primary antibody incubation 
 
1. Dilute the primary antibody with the blocking solution (1:100), add 50 µL of 
the previous solution in each well and incubate for ¾ h at room 
temperature (or overnight at 4°C).  
 
At this point, can be added water in the empty space near the wells to simulate 
the effect of a wet chamber.  
 
2. Do two washes with PBS/Tween 20 solution 0.1% during 5 min.  
 
3. Do another wash with PBS during 5 min. 
 
In a negative control condition primary antibody was not added, just blocking 
solution. In this way, it can be observed the specificity of secondary antiboby 
and it should not be seen any fluorescence. 
 
Incubation of secondary antibody and nucleus marking by HOECHST  
 
1. Dilute the secondary antibody with PBS/Tween 20 0.1% solution (1:1000) 
and add the same amount of nuclear stainer (HOECHST 1000x) and 
secondary antibody. Add 50 µL of the previous solution in each well and 
incubate during 1 h  at room temperature and in darkness condition. 
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2. Wash 5/6 times with PBS/Tween 20 0.1% during 5 min. 
 
Assembling 
 
1. After the last wash with PBS, collect the coverslips, previously put inside 
every well with the help of a croocked blunt bit and a clamp. Bathe the 
coverslips into distilled water and put them on the slides, previously 
prepared with a drop (3 µL) of PROLONG.  
 
2. Leave the slides become dry and store them until the following analisys by 
the microscope. 
 
The microscope analysis was done by a ‘’Leica 63x/1.40-0.6 oil zoom’’ 
microscope. A series of 10 photos were taken for each treatment and the photos 
were analysed afterwards with the programme ‘’ImageJ’’.     
 
2.7 PCNA immunohistochemistry 
 
The proliferating cell nuclear antigen (PCNA) is a 36 kDa molecular weight 
protein also known as cyclin. It was originally identified as an auxiliary factor for 
DNA polymerase δ and has been described as a DNA sliding clamp that acts as 
a polymerase processivity factor. PCNA aids in processivity through association 
with various DNA replication associated proteins. In addition to DNA replication, 
PCNA function is associated with chromatin remodeling, proliferation, sister-
chromatid cohesion, cell cycle control and DNA repair. In addition, PCNA is 
often used as a marker for cell proliferation. In cells fixed with organic solvents, 
PCNA is seen to be strongly associated in the nuclear regions where DNA 
synthesis is occurring, whereas in cells fixed with aldehydes the staining is more 
diffuse but intense and occurs throughout the cell cycle. This is due to the 
presence of two basic forms of the PCNA protein, a soluble form sensitive to 
organic fixation not involved in replication, and a second form that is insoluble 
and is associated with ongoing DNA synthesis. 
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Materials 
 
• Coverslips. 
• PBS. 
• Eppendorfs 1.5 mL. 
• Ethanol 70%. 
• Paraformaldehyde 4%. 
• Clamps.  
• Distilled water. 
• Kit PCNA. 
• Wet chamber to incubate the coverslips. 
• Different and gradational series of ethanol (70%, 80%, 90% and absolut). 
 
PCNA treatments  
 
At day 5 of cell culture the following treatments were tested:  
 
1. Control (Growth medium+DMSO) 
 
2. CA 50 µM 
 
3. HT 100 µM 
 
4. RGZ 1µM 
 
5. CA 50 µM + RGZ 1µM 
 
6. HT 100µM + RGZ 1 µM 
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Procedure 
 
Pre-treatment in culture 
 
1. Aspirate the medium from the wells with  the coverslips inside. 
 
2. Wash the wells three times with PBS. 
 
3. Add paraformaldehyde 4% in PBS and let rest during 15 min at room 
temperature to fix the cells.  
 
4. Aspirate the paraformaldehyde and add 70% ethanol for 5 min at room 
temperature (repeat twice). The plates can be stored at -20°C until the 
following step. 
 
5. Remove the coverslips from the wells by the clapms, previously bathed in 
ethanol, and let dry the coverslips totally. 
 
Staining protocol 
 
1. Put the coverslip in a wet chamber to incubate. 
 
2. Add 100 µL of blocking solution (reactive 1) to each sample and let 
incubate during 10 min. 
 
3. Dry the solution by absorbant paper. 
 
4. Add 100 µL of primary antibody anti-mouse (reactive 2) to each sample 
and let incubate in a wet chamder during 60 min. 
 
5. Wash the coverslips three times with PBS during two minutes to remove 
primary antibody. 
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6. Add 100 µl of STREPTAVIDINA-PEROXIDASE (reactive 3) to each 
sample and incubate during 10 minutes at room temperature.  
 
7. Do three washes with PBS for 2 min. 
 
8. Add two drops of reactives 4A, two of reactive 4B and two of reactive 4C 
of the PCNA kit (Invitrogen) in 1 mL of distilled water and mix the solution 
(CROMOGEN DAB). Protect the coverslips from the light during the 
following hour.  
 
9. Add 60 µL of CROMOGEN DAB (reactive 4) to each sample and let 
incubate for 5 min in a wet chamber. 
 
10. Add 100 µL of HEMATOXILINA (reactive 5) to each sample and incubate   
for 2 min. 
 
11. Wash the coverslips with current water and bathe them inside PBS, until 
the colour blue appears (about 30 min). Blue cells are not proliferative. 
 
12.  Dehydrate the coverslips doing two washes by a series of gradational 
alcohols (70%, 80%, 90% and absolut) and a final wash with xilol (50 µL 
for each sample.   
 
13. Once the coverslips are well dried, add 100 µL of HISTOMOUNT to each 
sample. 
 
14. Fix the coverslip on a slide and store them into a box for histology.      
 
The microscope analisys was done by an ‘’Olympus BX40 10x/0.25 optical’’ 
microscope and a series of 5 photos for each treatment were taken. The photos 
were analysed afterwards with the programme ‘’ImageJ’’.    
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2.8 RNA extraction, cDNA synthesis and qPCR 
 
Total RNA from adipose (100 mg), liver (50 mg) tissue and primary adipocyte 
cell cultures (3 wells) were extracted using TriReagent (Ambion) following the 
manufacturers’ recommendations. The quantity of isolated RNA was determined 
by spectrophotometry with a ND-2000 NanoDrop (Thermo Fisher Scientific). 
Afterwards, 500-1000 ng of total RNA were treated with Dnase I (Life 
technologies) following the manifacturers’ recommendations to remove all 
genomic DNA and further the RNA was reverse transcribed with the 
Transcriptor First Strand cDNA synthesis kit (Roche). 
 
Tissue homogenization  
 
Materials 
 
• Falcons. 
• Eppendorfs 1.5 mL. 
• TRI Reagent Solution (RNA reagent isolation). 
• Polytron. 
• MQ water (0.5-1 M). 
• NaOH (0.5-1 M). 
 
Procedure 
 
1. Add 1 mL of TriReagent solution to each falcon. 
 
2. Weigh samples (depending on tissue). 
 
3. Put samples inside every falcon together with TriReagent. 
 
4. Homogenize the samples by polytron: 2-3 times for 30 s at 12000 rpm. 
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5. Put homogenized samples into new eppendorfs. 
 
6. Centrifuge samples at 4°C for 10 min at 12000 rpm. 
 
7. Get only the upper part of the homogenated samples and reject pellet and 
lipids. 
 
8. Store the samples at -80°C until their use. 
 
Notes: TriReagent must be maintained always into ice; it is a reagent based on 
water and phenol which extracts nucleic acids and protects from RNAses 
degradation. 
 
RNA extraction from tissues 
 
Materials 
 
• Chloroform 
• Isopropanol 
• Ethanol 75% 
• Eppendorfs 1.5 mL 
• MQ water 
 
Procedure 
 
1. Put 200 µL of chlorophorm into each eppendorf with homogenated tissue 
and vortex for 20 s. 
 
2. Let rest for 5 min at room temperature so that we can have different 
phases. 
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3. Centrifuge at 4°C for 15 minutes at 13000 rpm; then there will be three 
well differentiated phases: a lower with chlorophorm, an intermediate with 
protein and a higher one which contains RNA plus water. 
 
4. Get only the upper phase and put it into new eppendorfs. 
 
5. Add 500 µL of isopropanol, that helps RNA to precipitate, and mix 4-5 
times by inversion. 
 
6. Let rest the samples for 10 min at room temperature. 
 
7. Centrifuge at 4°C for 10 minutes at 13000 rpm to obtain a higher aqueous 
phase and a white pellet, which contains RNA. 
 
8. Reject the aqueous part without touching the pellet. 
 
9. Add 1 mL of ethanol 75%. 
 
10. Centrifuge at 4°C for 5 minutes at 7500 rpm. 
 
11. Repeat the last three steps, so that we do two washes with ethanol 75%. 
 
12. Reject aqueous phase and dry pellet so that ethanol evaporates. 
 
13. Re-suspend pellet by adding 30 µL or less of RNAse Free water. 
 
14. Finally, quantify RNA samples by Nanodrop. 
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cDNA synthesis and retrotranscription 
 
DNAse treatment Kit  
 
Steps: 
 
1. Label  200 µL RNAse free eppendorfs. 
 
2. Calculate the amount of DEPC water in µL to use with Excel, based on the 
amount of RNA (µg). 
 
3. Prepare mix: DNAse (1µL) + Buffer (1µL) + 2-3 pipetting error. Keep on 
ice. 
 
4. Add the DEPC water corresponding to each sample (see Excel sheet). 
 
5. Add the amount of RNA from each sample except CNTC (control without 
RNA) (see Excel sheet). 
 
6. Add mix (2 µL/tube) and put the timer 15 min from the first sample (room 
temperature). 
 
7. After 15 min, add 1 µL of EDTA to stop reaction. 
 
8. Place tubes in PCR machine and select ‘’DNAse protocol’’ (10 min at 
65°C). 
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Retrotranscription Kit cDNA 
 
Steps: 
 
1. Label the final eppendorfs with sample code. 
 
2. Make a mix with oligodT’s (1µL) + Random hexamer (2 µL) + 2-3 pipetting 
error. Keep on ice. 
 
3. Add 10 µL from the samples to new eppendorfs. 
 
4. Add 3 µL of the mix per tube. 
 
5. Place tubes in PCR machine and select ‘’Denaturalization protocol’’ (10’ at 
65°C). 
 
6. Prepare  mix with buffer (4 µL + Protector (0.5 µL) + dNTPs (2 µL) + RT 
enzyme (0.5 µL) + 2-3 pipetting error. Keep on ice. 
 
7. Add 7 µL of mix per tube to all samples, except for CRTC (add water 
instead of RT enzyme). 
 
8. Place the eppendorfs in PCR machine and select ‘’RT protocol’’ 
(approximately 90 min). 
 
In vivo and in vitro RT-qPCR real time and gene expression analysis 
 
The analysis were performed using 2.5 µL of IQ SYBR Green Supermix (Bio-
Rad), 250 nM of forward and reverse primers and 1 µL of cDNA for each 
samples in a final volume of 5 µL. Reactions were performed in triplicate in 384-
well plates using an iCycler iQ Real-Time Detection System (Biorad), in the 
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same conditions previously described by Salmerón et al., 2013. Before the 
analyses, a dilution curve with a pool of samples was run to confirm primer 
efficiency and to determine the appropriate cDNA dilution. SYBR Green 
fluorescence was recorded during the annealing-extending phase of cycling. 
Negative controls (NTC: No Template Control; RTC: no Reverse Transcriptase 
Control and PCR: water) were included and ran in duplicate.  
 
2.9 Statistical analysis 
 
All data were analyzed using the statistical software IBM SPSS Statistics 19. 
Data were reported as mean values ± SEM (Standard Error of the Mean). For in 
vitro experiments, n=4 independent experiments were used. For in vivo 
experiments, n=9 fish were analyzed. To perform the statistical analyses, first 
the data were log10-transformed. Then, it was confirmed that the data were 
normally distributed according to the Shapiro-Wilk test and that presented 
homogeneity in the variance based on Levene test. Finally, statistical 
differences were analyzed by one-way ANOVA followed by Tukey post hoc test 
(Levene test not significant) or Dunnett test post hoc (Levene test significant). 
When the data did not follow the ANOVA presumptions, the non-parametric 
Kruskal-Wallis followed by Mann-Whitney tests were performed. Differences 
were considered statistically significant at P<0.05. 
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3. Caffeic acid/ Hydroxytyrosol in vitro results 
 
MTT results 
 
The effects of CA and HT on cell viability are reported in Fig. 9. CA and HT 
alone increased cell viability significantly. RGZ alone, instead, had no significant 
effect on cell viability and when combined with CA or HT reduced their positive 
effects slightly.  
 
 
 
Fig. 9. Effects of CA, HT and RGZ on rainbow trout adipocytes cell viability. Cell 
viability was identified by the addition of MTT reagent at day 5 of cell culture 
during 3 h. Data is shown as mean ± SEM (n=4). Different letters indicate 
significant differences (P<0.05). CA= caffeic acid, HT= hydroxytyrosol, RGZ= 
rosiglitazone.  
 
PCNA results 
 
Regarding cell proliferation, measured as percentage of PCNA-positive cells, 
(Fig. 10) statistical significant differences among the treatments were not 
observed. 
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Fig. 10. Effects of CA and HT on proliferation in rainbow trout adipocytes at day 
5 of cell culture. Data is shown as mean ± SEM (n=4). Values were considered 
significant at P<0.05. CA= caffeic acid, HT= hydroxytyrosol, RGZ= rosiglitazone.  
   
ORO results 
 
In the case of ORO assay (Fig. 11), it was observed a clear anti-obesogenic 
effect of HT. In fact, in the treatment in which it was placed in combination with a 
lipid mixture, this substance showed a significant decrease of lipid specific 
content, compared to the control or lipid alone. Concerning CA, it had a 
tendency to decrease the specific lipid content, combined with lipid, but not 
significantly. Lipid alone increased the specific lipid content slightly. 
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Fig. 11. Effects of CA and HT on the specific lipid content in raibow trout 
adipocytes at day 7 of cell culture during 2 h. Error bars represent a standard 
error ± SEM of 4 independent experiments. Different letters indicate significant 
differences (P<0.05). CA= caffeic acid, HT= hydroxytyrosol, LIP= lipid mixture. 
  
Immunofluorescence results 
 
As regards to the immunofluorescence assay to detect PPARγ (Fig. 12), both 
CA and HT, combined with RGZ, reduced significantly the obesogenic effect of 
RGZ, decreasing the fluorescence at the control level, symptom of a lesser 
expression of the PPARγ. As it can be observed in fig. 13, RGZ alone promoted 
signal intensity of PPARγ expression with evidence. 
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Fig. 12. Effects of CA and HT on signal intensity in rainbow trout adipocytes cell 
culture at day 7. Data is shown as mean ± SEM (n=4). Signal intensity is relative 
to the control. Different letters indicate significant differences (P<0.05). CA= 
caffeic acid, HT= hydroxytyrosol, RGZ= rosiglitazone.  
     
                                   
 
                   
 
 
 
Control                                     RGZ 
 
 
                    
 
 
 
 
Fig. 13. Immunofluorescence representative of PPARy images from 4 
independent experiments taken by a Leica 63x/1.40-0.6 oil zoom 
Control 
 
HT+RGZ CA+RGZ 
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epifluorescence microscope. CA= caffeic acid, HT= hydroxytyrosol, RGZ= 
rosiglitazone.  
 
In these images from the same immunofluorescence assay taken by a confocal 
microscope (Fig. 14) we can see the differences among the treatments respect 
to the control. As it can be observed either from the graph (Fig. 12) or from the 
epifluorescent microscope (Fig. 13), RGZ promoted signal intensity, while in 
combination with CA or HT, this effect was decreased. 
 
 
 
Fig. 14. Immunofluorescence representative images from 4 independent 
experiments taken by confocal microscope. In cells treated with the stain 
Hoescht we can observe nuclei coloured in blue; in the red photos 
luminescence is proportional to PPARγ expression. CA= caffeic acid, HT= 
hydroxytyrosol, RGZ= rosiglitazone.  
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qPCR results 
 
The relative expression of different adipogenic genes, in response to the 
different treatments, is shown in fig. 15. No significant differences among the 
treatments were observed for FAS or LPL gene expression (Figs. 15A and 15B). 
The highest mRNA expression levels of HSL (Fig. 15C) were found in the 
treatments where a lipid mixture was put, whereas lower levels compared to the 
control were observed when RGZ was added. CA and HT did not cause any 
variation to HSL expression when combined, neither with RGZ or lipid. PPARγ 
resulted significantly up-regulated in the presence of a lipid mixture (Fig. 15 D). 
In combination with lipid, both CA and HT, tended to decrease the lipid effect on 
PPARγ regulation. On the other hand, RGZ determined only a slight rising in 
PPARγ expression, but not significantly, even when combined with CA or HT. 
Concerning C/EBPα (Fig. 15E), only lipids increased the expression of this gene 
significantly. CA and HT, on the contrary, had a tendency to limit the lipid effect 
on C/EBPα expression. RGZ raised C/EBPα regulation slightly, even in the 
presence of CA and HT.  
 
Gene  Sequence 5’-3’ (F+R) Annealing temperature 
Ubiquitin 
ACAACATCCAGAAAGAGTCCAC 
AGGCGAGCGTAGCACTTG 
 
58 
EF1ɑ 
CTTCAACGCTCAGGTCATCAT 
GCACAGCGAAACGACCAAGGGGA 
 
59 
β-actin 
ATCCTGACAGAGCGCGGTTACAGT 
TGCCCATCTCCTGCTCAAAGTCCA 
 
62 
FAS GAGACCTAGTGGAGGCTGTC TCTTGTTGATGGTGAGCTGT 54 
LPL 
GAGCACGCAGACAACCAGAA 
GGGGTAGATGTCGATGTCGC 
 
59 
PPARγ 
GCCAGTACTGTCGCTTTCAG 
TCCATAAACTCAGCCAGCAG 
 
60 
C/EBPɑ 
TGTGGCGATAAAGCAAGAGC 
CTGGTGGGAATGGTGGTAGG 
 
57 
            HSL 
AGGGTCAATGGTCATCGTCTC 
CTTGACGGAGGGACAGCTAC 
 
58 
 
Table 1. Rainbow trout primer sequences (Forward and Reverse) used for in 
vitro real-time PCR. 
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Fig. 15. Relative expression of the genes FAS (A), LPL (B), HSL (C), PPARγ 
(D) and C/EBPα (E) in rainbow trout primary cultured adipocytes under different 
treatments. EF1α, ubiquitin and β-actin were used as reference genes. Values 
are reported as mean ± SEM of 4 independent cultures. Different letters indicate 
significant differences between treatments at P<0.05. FAS= Fatty acid synthase, 
LPL= Lipoprotein lipase, HSL= Hormone-sensitive lipase, PPARγ= Peroxisome 
proliferator-activated receptor gamma, C/EBPα= CCAAT/enhancer binding 
protein alpha.   
 
 
 
A B C 
D E 
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3.1 Caffeic acid/ Hydroxytyrosol in vivo results 
 
The relative expression of different adipogenic genes and related oxidative 
stress genes, in response to the treatments used (Control, CA 10µg/g, HT 
20µg/g), is shown in fig. 16. Concerning adipose tissue (Fig. 16A), none of the 
mRNA expression levels of the genes examined showed significant differences 
among the treatments with the exception of FAS, where the mRNA levels were 
influenced by the treatments slightly. In particular, CA had a tendency to 
decrease FAS levels while HT produced a net and significant fall of FAS 
expression, compared to the control.  
In liver (Fig. 16B), HT decreased IGF-II transcript levels significantly but it did 
not produce any significant effect on the expression of the other genes 
analyzed. It was just observed a mild but not significant rising in GHR-II and 
GPX1 levels produced by HT. CA, instead, had a significant effect on GHR-I, 
GHR-II and GPX1 levels, increasing their mRNA amount visibly.      
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Table 2. Rainbow trout primer sequences (Forward and Reverse) used for in 
vivo real-time PCR. 
 
Gene  Sequence 5’-3’ (F+R) Annealing temperature 
Ubiquitin 
ACAACATCCAGAAAGAGTCCAC 
AGGCGAGCGTAGCACTTG 
 
58 
EF1ɑ 
CTTCAACGCTCAGGTCATCAT 
GCACAGCGAAACGACCAAGGGGA 
 
59 
β-actin 
ATCCTGACAGAGCGCGGTTACAGT 
TGCCCATCTCCTGCTCAAAGTCCA 
 
62 
FAS GAGACCTAGTGGAGGCTGTC TCTTGTTGATGGTGAGCTGT 54 
GHR1 
CGTCCTCATCCTTCCAGTTTTA 
GTTCTGTGAGGTTCTGGAAAAC 
 
55 
GHR2 
TCTCCTCATCCTAACAGTTGTG 
GCTCTGTGAGGTTCTGGAATGT 
 
55 
IGF1 
TGGACACGCTGCAGTTTGTGTGT 
CACTCGTCCACAATACCACGGTT 
 
64 
IGF2 
CGGCAGAAACGCTATGTGGA 
TGCTGGTTGGCCTACTGAAA 
 
60 
IGFR1ɑ 
AGAGATAGACGACGCCTCCTA 
CACCAAATAGATCCCTACGT 
 
54 
GPX1 
CGAGCTCCATGAACGGTACG 
TGCTTCCCGTTCACATCCAC 
 
60 
HPGPX 
TTGGAGGTCAGGAGCCAGGT 
ACCCTTTCCCTTGGGCTGTT 
 
60 
SOD 
CCATGGTAAGAATCATGGCGG 
CGTGGATCACCATGGTTCTG 
 
54 
TR 
ACCGTGCAGCCTAGAATGCT 
GTGATGTCTCTCTTTGCAGTTCCTT 
 
58 
 
 
 
 
 
 
 
 
 
 
 
 
 69 
A 
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Fig. 16. Relative expression of the genes FAS, IGF-I, IGF-II, IGFR-Iα, GHR-I, 
GHR-II, GPX1, HPGPX, SOD and TR in adipose tissue and liver of rainbow 
trout under different treatments (Control, CA 10µg/g, HT 20µg/g). EF1α, 
ubiquitin and β-actin were used as reference genes. Values are reported as 
mean ± SEM (n=9). Different letters indicate significant differences between 
treatments at P<0.05. FAS= fatty acid synthase, IGF-I= insulin-like growth 
factor-1, IGF-II= insulin- like growth factor-2, IGFR-Iα= insulin-like growth factor 
receptor-Iα, GHR-I= growth hormone receptor-1, GHR-II= growth hormone 
receptor-2, GPX1= glutathione peroxidase1, HPGPX= phospholipid-
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hydroperoxide glutathione peroxidase, SOD= superoxide dismutase, TR= 
thioredoxin-disulfide reductase. 
 
4. Discussions 
 
In vitro results confirmed our initial assumption: the potential anti-obesogenic 
effects of the compounds CA and HT on the adipose tissue of the rainbow trout 
(O. mykiss). All in vitro tests were carried on to test this hypothesis and resulted 
in accordance among them; only results from proliferating cell nuclear antigen 
(PCNA) assay were not significant. In the MTT assay it was observed that CA 
and HT, used alone in the treatments, increased cell viability appreciably. Cell 
viability was not affected in presence of RGZ (an agonist of PPARγ). Differently 
from our MTT results, in a study made on 3T3-L1 cells of rats, it was observed 
that neither of the phenolic compounds (HT and OL) used in the experiment 
produced any significant effects on cell viability at the concentrations used (0, 
100, 150, 200 µmol/L) in the experiment (Drira et al., 2011). The increase in cell 
viability observed does not necessarily mean that our result is not in agreement 
with this last study, in fact we can obtain a higher amount of cells but not 
differentiated. What does not agree is the fact that we do not see changes in 
PCNA. Moreover, both HT and OL exhibited anti-adipogenic effects essentially 
in the early stage of cells differentiation, in fact their effects during the middle 
and late stages were very low, with no significant differences seen between the 
control and the treated cells (Drira, et al., 2011). In addition, it was seen by Drira 
et al. (2014) that HT attenuated triglyceride accumulation and stimulated 
glycerol release in fully differentiated adipocytes in a dose- and time-dependent 
manner (Drira, et al., 2014). To test the effects of CA and HT on rainbow trout 
pre-adipocytes proliferation, PCNA test was carried on, but we did not obtain 
any significant result from this test. From the ORO assay, emerged that lipids 
had a mild adipogenic effect, in fact they tended to increase the specific lipid 
content in rainbow trout adipocytes, which is in agreement with the fact that lipid 
mixture is important in trout adipocyte differentiation (Bouraoui, et al., 2008). In 
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Salmon pre-adipocytes, it was observed also that they differentiate only in the 
presence of lipid mixture (Vegusdal et al. 2003). CA and HT, instead, did not 
contribute to the amount of adipocytes in rainbow trout adipose tissue, even in 
association with lipids. A previous study conducted by Shin et al., (2014) 
showed that 40µM of caffeic acid phenethyl ester (CAPE) completely inhibited 
adipogenesis of 3T3-L1 preadipocytes. Moreover, the same authors proved 
that, in rats fed with high fat diet, CAPE showed decreased level of adiposity in 
a dose-dependent manner. We also observed, by immunofluorescence assay, a 
reduced expression of PPARγ, which is the main promoter of adipogenesis, 
caused by the action of CA and HT, even when these two compounds are along 
with RGZ. Unfortunately, we do not have any specific study on the effects of CA 
and HT in fish to make a comparison with, only many works done in mammals. 
For example, it was previously demonstrated in other studies (Juman et al., 
2010a; Warnke et al., 2011) that CA and HT were able to inhibit adipocytes 
differentiation and cell lipid content in mammals through an inhibition of PPARγ 
expression. In a study published by the same authors (Juman et al, 2010b) it 
was shown how the addition of CA during adipocytes differentiation of 3T3-L1 
mouse fibroblasts cells produced a reduction in intracellular lipid storage. 
Treatments with CA, through staining with ORO, caused a dose-dependent 
suppression on oil droplet accumulation, a reduction in the size of the same 
droplets and a significant decrement in triglycerides deposition (Juman et al., 
2010b). These results suggest that CA usage could be negative for the process 
of adipocytes differentiation.   
As regard for HT, it was suggested that short-term control mechanisms of fatty 
acid and cholesterol synthesis by HT and high phenol extract, such as OL, were 
effective in liver cells determining a strong inhibition in total synthesis of 
cholesterol, fatty acids and neutral lipids in vivo and in vitro treatments (Jemai et 
al, 2008; Park et al, 2011; Priore et al, 2014). These data is in support of our 
results. 
To have a more complete view about the effects of CA and HT on rainbow trout 
adipocytes differentiation, in vitro qPCR was performed. The results obtained, in 
agreement with our previous in vitro results, showed that the two compounds 
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had a mild anti-adipogenic effect. In fact, CA and HT tended to decrease 
PPARγ and C/EBPα expression, even if not in a significant way. HT alone, also 
up-regulated  HSL mRNA levels slightly. Lipids, instead, increased PPARγ and 
C/EBPα  expression significantly, in agreement with Vegusdal et al., (2003). 
According to these authors, the first evidence of the adipogenic process was the 
accumulation of lipid droplets: one or more components of the lipid mixture 
acted as a adipogenic factors, and the mixture also provided cholesterol and 
lipids for the fat droplets that were increasing in number and size (Vegusdal, et 
al., 2003). In addition, lipids increased FAS slightly, in concordance with its 
obesogenic effect. In fact FAS is a key enzyme involved in de novo lipogenesis 
that catalyzes the synthesis of long chain fatty acids, mainly by catalyzing acetyl 
coenzyme A and malonyl coenzyme A (Smith et al., 2003). However, FAS gene 
cloning is limited in fish, and data on its gene expression are scarce (Weil et al., 
2013). No effect by Lipids, CA and HT was seen on LPL, that is considered a 
key enzyme in lipid deposition and metabolism in mammals and in fish 
(Bouraoui, et al., 2011), and it is one of the precocious markers of preadipocyte 
differentiation into mature adipocytes (Weil, et al., 2013). 
Regarding RGZ, it was observed no effect on FAS and LPL, but a slight down-
regulation of HSL and a mild up-regulation of PPARγ and C/EBPα. In support of 
these results, RGZ is an agonist of PPARγ (Semple et al, 2006) and it belongs, 
along with troglitazone, to the drug class of Thiazolidinediones (TZDs), known 
as specific anti-diabetic agents that decrease plasma glucose levels and 
enhance insulin sensitivity in obese mammals (Olefsky and Saltiel, 2000; 
Lebovitz, 2002; Reynolds and Goldberg, 2006). TZDs induce differentiation of 
preadipocytes in a wide variety of cell culture systems (Tafuri, 1996; Hausman 
et al., 2008) via activation of PPARγ, which is considered one of the main 
transcription factors involved in the regulation of adipocyte differentiation (Rosen 
et al., 1999; Hammarstedt et al., 2005). During this process, the TZDs promote 
uptake of glucose and fatty acids, storage of TAG and production of adiponectin 
(Yki-Jarvinen, 2004; Tontonoz and Spiegelman, 2008). 
An in vitro study done on 3T3-L1 mouse adipocytes by Drira et al. (2014), was 
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shown that HT down-regulated HSL, in contrast with our result, in which HT up-
regulated slightly HSL expression in rainbow trout adipocytes. On the contrary, 
our results are in concordance with the role HSL plays both in mammals and 
fish, namely it is the principal enzyme that catalyzes the hydrolysis of TAGs 
(triglycerides). In particular, it is involved in the first two steps of this process 
(breakdown of TAG into dyacylglycerol (DAG) and then into monoacylglycerol 
(MAG), (Weil et al., 2012). In addition, diet composition can modify HSL activity; 
in fact, it was showed that basal lipolysis increased in visceral mature 
adipocytes collected from gilthead seabream fed with plant enriched diets (Cruz-
Garcia et al., 2011) or without vegetable oils. (Albalat et al., 2005a), 
corroborating our results. 
Adipocyte differentiation is induced by a series of programed changes in gene 
expression in mammals (Hwang et al. 1997) as in fish. In both of them PPARγ 
and C/EBPα are key adipogenic transcription factors (Tchkonia et al., 2002), 
that activate adipocyte-specific genes and are involved in the growth arrest 
required for adipocyte differentiation (Niemela et al., 2007).  
However, while PPARγ is considered the master regulator of adipogenesis, so it 
can induce adipogenesis in C/EBPα-deficient cells, C/EBPα, on the contrary, is 
incapable of driving the adipogenic program in the absence of PPARγ (Rosen et 
al., 2002). This observation suggests that C/EBPα and PPARγ participate in a 
single pathway of adipose development, in which the second one is the 
dominant factor (Farmer, 2006). Moreover, it was seen that these two 
transcription factors are necessary for the transition of pre-adipocytes into 
adipocytes in vitro (Bouraoui, et al., 2008). In this way, as just said, this 
confirmed our hyphotesis from the in vitro results about the role of CA and HT 
on PPARγ and C/EBPα mRNA levels, and thus inhibiting adipogenesis. 
Moreover, in support of these results, Drira et al. (2014) demonstrated that HT 
down-regulated the expression of PPARγ and C/EBPα also in 3T3-L1 mouse 
adipocytes. 
In vivo results showed a anti-obesogenic effect of HT in adipose tissue, as 
observed by the significant decrease in FAS gene expression. Regarding 
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oxidative stress, we could hypothesize an eventual anti-oxidant role of CA in 
liver. In adipose tissue oxidative-stress related genes were not differentially 
expressed. In liver, CA was seen to increase GHR-I and GHR-II expression, but 
no effect was observed on IGF-II. A possible explanation could be that the 
relative contribution of fish GHRs on IGF regulation probably depends on many 
factors, such as fish lineage, age, nutritional and environmental condition 
(Saera-Vila et al., 2007). Differently, in non-salmonid fish, as gilthead seabream, 
it was highlighted the key role of GHR-I in the tissue-specific regulation of IGFs, 
but not of GHR-II. 
We took into account GH hormone (even if not measured in our experiments) 
and its GHRs receptors because it is not only linked with growth, but also 
involved in other processes, among which metabolism (Bjornsson et al., 2004; 
Norrelund, 2005). In particular, in fish as in mammals, GH is an anabolic protein 
while promoting lipid and carbohydrate breakdown. In fact, the lipolytic effect of 
GH in fish was first demonstrated in adipose tissue and liver of juvenile coho 
salmon in vivo (Sheridan, 1986) and GH was also shown to directly stimulate 
lipolysis in liver isolated from rainbow trout (O’Connor et al., 1993) and adipose 
tissue isolated from seabream (Albalat et al., 2005). GH also exerted an anti-
lipogenic effect in the liver of gilthead seabream, in which it regulated acetil-CoA 
carboxylase (Yin et al., 1998). More recently, Norbeck et al. (2007) 
demonstrated that, during periods of food deprivation, lipid depletion is 
accompanied by increases in plasma levels of GH in the face of reduced plasma 
levels of insuline and IGF-I in mammals and fish (Norbeck et al., 2007). In line 
with that we said previously, Bergan et al., (2012) showed that fasting-induced 
lipolysis in trout liver (as well as in adipose tissue and red and white skeletal 
muscle) was accompanied by the deactivation of Akt, JAK2, STAT5 and by the 
activation of ERK and PKC. In particular, GH stimulated lipolysis during fasting 
through the activation of PKC and ERK in conjunction with the deactivation of 
PI3K/Akt and JAK-STAT, enhancing the expression of HSL mRNA levels, as 
well as phosphorilating HSL via the activation of PKC and ERK (Bergan et al., 
2013); even if the mechanisms of action involved in GH proliferative and 
metabolic effects in fish are not well known (Bergan et al., 2013). 
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Furthermore, in a previous study on rainbow trout (Norbeck et al., 2007), it was 
demonstrated that decreased hepatic sensitiveness to GH was also supported 
by reduced hepatic levels of GHR-I and GHR-II, so that, in our work, an 
increase in hepatic levels of GHRs caused by CA could determine the contrary 
effect as on trout hepatocytes, making them more responsive to GH action in 
the liver. Moreover, considering the fact that the actions of GH are initiated by 
binding to the GHR on the cell membrane of target tissues, we can suppose that 
CA increasing GHRs mRNA levels could be enhancing an eventual lipolytic 
action of GH in rainbow trout liver (Norbeck et al., 2007). 
In adipose tissue, as CA in liver, it was seen that HT had a possible lipolytic 
effect, decreasing FAS strongly. In fact, FAS, as we said previously, is involved 
in lipogenesis (Wakil, 1989). 
Regarding CA and HT effects on oxidative-stress related genes in liver, only 
GPX1 was significantly expressed, among the genes analyzed (SOD, TR and 
HPGPX). In particular, it was observed an up-regulation of GPX1 by CA, having 
an indirect effect against oxidative stress by modulating gene expression and 
enzyme activity, which enhances enzymatic antioxidant defenses (Oliveras-
Lopez et al., 2008). HT, instead, had only a tendency to up-regulate GPX1. 
In concordance with these results, it is known that to decrease reactive oxygen 
species levels and avoid lipid peroxidation, all aerobic organisms possess two 
types of antioxidant defense systems. One is represented by enzymes and 
includes superoxide dismutase (SOD), catalase (CAT) and glutathione 
peroxidase (GPX). SOD is a metalloenzyme that catalyses the dismutation of 
the superoxide anion (O2- ) into oxygen and H2O2  (Fridovich, 1997). The Cu/Zn-
SOD is located in the cytosol and nucleus, while Mn-SOD is localized within the 
mitochondrial matrix. Subsequently, H2O2 is reduced to water by CAT in the 
peroxisomes. GPX catalyses the same reaction as CAT in the cytosol and also 
converts lipid hydroperoxides into lipid hydroxides, which are more stable 
products (Fontagnè et al., 2008). 
In mammals, several studies were done on the effects of polyphenolic 
compounds derived from extra virgin olive oil, such as HT, on oxidative stress. 
For example, in a study carried on mice by Oliveras-Lopez et al. (2008), it was 
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observed that olive oil exerted both a direct and an indirect anti-oxidant activity 
through an up-regulation of SOD, CAT and GPX expression in mice liver 
(Olivera-Lopez et al., 2008). In mammals, it was reported that, as HT, also CA 
can have anti-oxidant effects (Li et al., 2015). In a work on rats it was 
demonstrated that CAPE had an anti-oxidant role in liver, with a dose-
dependent increase of SOD and CAT mRNA levels. In another study, 
Karthikesan et al. (2007), found similar results to the previous work, with an 
increase in the level of enzymic antioxidants enzymes (SOD, GPX, CAT) in rat 
liver produced by a dose of CA (12 mg/kg of body weight). 
Unfortunately, we have not specific in vivo studies in fish regarding the effects of 
CA and HT on the oxidative stress, but just a few works on natural products 
such as propolis and olive oil, containing CA and HT respectively. For example, 
a study on rainbow trout showed that propolis (10ppm) had in vivo anti-oxidant 
activity, with an increase of malondialdehyde (MDA) levels and catalase (CAT) 
activities in spleen and heart tissues, showing significant therapeutic effects 
(Aldemir et al., 2014). Similar in vivo effects of propolis were shown in another 
study on carp (Cyprinus carpio) liver, gill and muscle tissues by Talas et al., 
(2014). A case-study made in cod liver (De Leonardis et al., 2001) reported that 
elevated doses of CA could preserve the original fish oil composition and limit 
the loss of its nutritional quality, inhibiting its double-bond conjugation, so 
reducing the decrement of PUFA-n3. Concerning HT, it was seen how this 
substance, in nutritionally relevant amounts, is able to positively modulate the 
glutathione-driven antioxidant enzymatic machinery in the adipose tissue, 
probably via homeostatic feedback (Giordano et al., 2014).  
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5. Conclusions 
 
• CA and HT significantly increase cell viability in vitro, although they do not 
affect cell proliferation. 
• CA and HT suppress the increase in lipid content caused by lipids and the 
protein expression of PPARγ by RGZ in rainbow trout adipocytes, 
demonstrating they are anti-obesogenic compounds. 
• CA and HT in vitro do not show any effect on lipogenic genes (FAS and 
LPL) and only slightly affect the induction of the lipolytic gene HSL, 
caused by the lipid mixture. 
• Lipid mixture significantly increase the gene expression of the 
transcriptional markers (PPARγ and C/EBPα) while CA and HT slightly 
decrease this effect, supporting their anti-adipogenic role. 
• In vivo HT has a clear anti-obesogenic role, strongly reducing FAS 
expression in rainbow trout adipose tissue; CA has a potential anti-
obesogenic effect in trout liver, enhancing GHR-I and GHR-II expression. 
• A possible antioxidant action of CA is observed in rainbow trout liver in 
vivo. 
 
Further studies would be useful and necessary in the future to better clarify the 
effects of antioxidant and anti-obesogenic compounds on fish target tissues, 
responding to the growing demand of aquaculture products and to improve in 
this way the flesh taste and quality.  
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